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Abstract 
The use of passive compression has been extended from a clinical treatment to an elective tool 
used by healthy individuals in an attempt to improve exercise performance. The rationale being that 
graduated compression socks would enhance the capabilities of the muscle pump and therefore increase 
venous return to the heart, leading to increased cardiac efficiency and better exercise performance. There is 
currently conflicting evidence regarding the effectiveness of graduated compression socks on improving 
central and peripheral hemodynamics in a healthy population. These conflicting results are believed to be 
due to varying test protocols (e.g., type of exercise, duration, and intensity), difference in study populations 
(e.g., normal participants vs. highly trained athletes), and the variation in the reported strength of the 
applied pressure (i.e., only reporting the manufacturer’s operating pressure). All of these factors make it 
difficult to draw concrete conclusions on the effect of compression during exercise and recovery.  
The goal of this study was to complete a set of controlled experiments to assess the effectiveness 
of passive compression in healthy subjects and whether they are beneficial for enhancing performance and 
recovery. The purpose being to compare the results to the discrepancies found in current literature when 
evaluating external compression in healthy subjects. The scope involved testing 12 healthy individuals who 
ranged in fitness levels during a simple exercise task while monitoring central and peripheral variables. The 
experimental protocol involved a three minute baseline period, followed by plantar flexion exercises for 
five minutes at a rate of 20 raises per minute, and finished with a five minute recovery time. The protocol 
was repeated twice to investigate the physiological response with and without graduated compression 
socks. Subjects completed testing on two days, with at least 48 hours between tests, to determine the 
repeatability of the results. Specific central variables investigated included heart rate, systolic blood 
pressure, diastolic blood pressure, and cardiac output. Peripherally, popliteal arterial blood velocity, 
popliteal arterial blood flow, popliteal artery diameter, muscle activity, muscle oxygenation, and the change 
in pressure from the ankle to knee due to the compression sock were measured.  
  The results indicated that there were no changes in the central hemodynamics with the addition of 
the socks. At the peripheral level, there were no significant changes in popliteal artery diameter, mean 
popliteal arterial blood velocity, or mean popliteal arterial blood flow during any of the testing conditions.  
During exercise, there was an indication that the subjects who experienced an increase in mean popliteal 
arterial blood velocity or mean popliteal arterial blood flow with the graduated compression socks behaved 
more consistently than those who experienced a decrease, as implied by lower standard deviation values. 
The exercise task did not cause any lasting effects on vasculature as there was no significant difference 
between the popliteal artery diameter values for baseline and recovery and the subjects experienced the 
same response (i.e., increase or decrease) with the socks during both baseline and recovery.  For muscle 
oxygenation, results indicated a decrease in blood volume in the leg with the graduated compression socks, 
and a trend towards increased muscle oxygenation and oxygen extraction during exercise. For recovery, 
there was a trend towards a lower blood volume in the leg with the graduated compression socks implying 
 iv 
that even post exercise the socks were working to prevent pooling in the leg. For muscle activity, the same 
muscle activation was required with and without the socks to complete the test. The height at which the 
plantar flexion task was completed was tied to lifestyle, those subjects reporting irregular exercise, 
completed the calf raise exercise at lower heights than those who reported frequent exercise. Furthermore, 
the locally applied pressure was found to vary dynamically during exercise and then return to baseline 
values during recovery. Moreover, the strength of the pressure change on the leg from ankle to knee was 
not correlated to the response of the subject for any of the investigated variables. Finally, no significant 
differences were found in the immediate hemodynamic recovery time with the addition of the sock.   
 
The results found in this study were comparable to other studies investigating the effect of 
graduated compression socks on hemodynamics. It is not surprising that there were no changes in central 
hemodynamics, as the external pressure was applied in such a small, localized region. It is also not 
unexpected that a healthy study population did not lead to significant changes in vascular diameter or blood 
velocity since the subjects do not suffer from venous deficiencies. The key findings of this study are that 
the graduated compression socks were beneficial in decreasing blood volume in the leg, as expected with 
their prescribed function, and have the potential to increase oxygen extraction in a healthy population. 
Furthermore, the discovery that the local applied pressure varied during exercise should be taken into 
consideration when utilizing compression socks for various exercise tasks.  Finally, this study highlights 
the importance of control and reporting all aspects of the experimental protocol and data analysis in order 
to obtain high fidelity results that can be entered, with confidence, into the debate of the effectiveness of 
graduated compression socks on athletic performance.  
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Chapter 1 
Introduction 
In recent years, the use of graduated compression socks (GCS) has been extended from their 
traditional use as a clinical tool into the sports market, where athletes are now using compression while 
running, biking, or performing other endurance sports with the belief that they will increase their 
performance and/or decrease recovery time
 1, 2
. The traditional use of GCS is to prevent pooling of blood in 
the legs, typically for patients suffering from edema, via passive compression
 3-5
. While the clinical use of 
passive compression has been proven effective, further research is required into its use by healthy active 
populations. Recent research presents conflicting results as to whether the use of passive compression is 
beneficial for a healthy population. The human muscle pump works effectively to aid in the return of blood 
back to the heart from the lower limbs and increase cardiac efficiency and it is the aim of this research 
project to investigate if this effect could be amplified with the addition of externally applied compression to 
work in conjunction with the muscle pump, potentially providing a basis for improvement in athletic 
performance. This chapter will provide background on the cardiovascular system and muscle pump as well 
as the theory behind passive compression and a discussion of the literature testing compression both in 
clinical and exercise applications.  
1.1 Background 
1.1.1 Overview of the Cardiovascular System  
The human cardiovascular system is a complex parallel flow network that circulates blood 
throughout the body (Figure 1.1). It can be thought of in terms of a closed system containing a series of 
tubes (blood vessels) divided into two circulation pathways that are connected to a pump (the heart). The 
first circulation pathway is the pulmonary circulation, where blood is carried from the heart to the lungs 
and back to the heart
 6
. The second circulation pathway, the systemic circulation, delivers blood to the 
organs and tissues, excluding the lungs, and returns blood to the heart. The cardiac cycle consists of two 
phases, systole and diastole. During systole the cardiac muscle contracts and blood is forced out of the heart 
and into the pulmonary and systemic circulation systems. During diastole, the heart muscle is relaxed and 
the heart fills with blood. The heart contains four chambers, the right atrium, the left atrium, the right 
ventricle, and the left ventricle. The right atrium receives deoxygenated blood returning to the heart from 
the systemic circulation (venous return). This blood is then drawn into the right ventricle where it is 
pumped into the lungs (pulmonary circulation) to become oxygenated. Oxygenated blood returns to the 
heart through the left atrium, where it is subsequently drawn into the left ventricle and pumped back into 
the systemic circulation to deliver oxygen and nutrients to the body’s cells while it simultaneously removes 
cellular waste for excretion
 6
. 
Blood circulates throughout the body through a series of vessels; arteries are the blood vessels that 
carry blood away from the heart, while the veins return the blood to the heart. As blood moves through the 
 2 
body, valves in the heart and veins help ensure that blood flows in one direction
 7
. When blood leaves the 
heart via the main artery, the aorta, it is dispersed through a network of arterial vessels that branch and 
decrease in diameter with increasing distance from the heart
 7
. The pulsatile character of the flow, induced 
by contraction of the heart, is dampened as the blood travels to smaller arteries, arterioles (smallest vessel 
in the arterial circulation), and eventually reaches the smallest vessels in the body, the capillaries, where the 
exchange of oxygen, carbon dioxide, water, and other nutrients and cellular waste occurs
 6, 7
. The 
capillaries, located within the organs and tissues, collect into the venules (smallest vessel in the venous 
circulation) and then into successively larger veins that increase in diameter as the distance to the heart 
decreases
 6, 7
.  
 
Figure 1.1: An illustration of the human circulatory system 
(adapted from idHumanBody 
 8
) 
The rate at which blood circulates through the vessels (volumetric flow rate of blood) is extremely 
important, as it is essential in maintaining the health of the body. As previously mentioned, the exchange of 
oxygen, nutrients, and waste occurs at the capillaries. With good blood circulation this exchange will occur 
continuously and meet the body’s oxygen and nutrient demands to maintain homeostasis. Poor blood 
circulation decreases the frequency of the exchange and slows the delivery of oxygen and nutrients to 
organs and tissues, increasing the risk for serious health issues. The volumetric flow rate of blood (F) is 
related to the driving pressure gradient (PG) and frictional resistance (R) in a vessel, as  
 
  
  
 
 Equation 1.1 
 
 
   Venous 
Circulation  
  Arterial 
Circulation  
 3 
The pressure gradient term, seen in Equation 1.1, will normally be maintained within a small 
range due to compensatory mechanisms of the cardiovascular system that work to regulate blood pressure, 
as it provides the driving force for organ perfusion
 7
. The body regulates blood pressure through negative 
feedback systems, which incorporate pressure sensors called baroreceptors
 9
. Baroreceptors respond to 
stretching of the vessel walls that are generated by increases in arterial pressure
 9
. Each baroreceptor has its 
own threshold and sensitivity to changes in pressure, and as pressure increases additional receptors are 
recruited
 9
. Therefore, if blood pressure starts to rise, activation of the baroreceptors will cause heart rate to 
decrease, which will in turn cause blood pressure to decrease. If blood pressure starts to decrease below a 
certain threshold, the opposite effect will occur and heart rate will increase, which will lead to an increase 
in blood pressure. These changes in blood pressure due to the activation of baroreceptors are mediated by 
the parasympathetic and sympathetic nervous systems
 9
. 
Due to the regulation of blood pressure, the flow rate becomes mainly dependent on vessel 
resistance. The resistance within a vessel is related to the vessel length (L), blood viscosity (η), and radius 
of the vessel (r) as shown in Equation 1.2
 7
. Blood viscosity is related to friction generated by the 
interactions within the fluid as the blood is flowing (i.e. between fluid molecules in the plasma and red 
blood cells
 7
). The resistance of a given vessel is most sensitive to the vessel radius, being inversely 
proportional to the fourth power. Thus, as the radius of the vessel decreases, the resistance will significantly 
increase. Furthermore, the circulatory system continuously branches into a highly parallel system. This 
continuous branching, as well as the reduction in diameters of vessels as the distance from the heart is 
increased, leads to dramatically reduced flow rates in smaller vessels compared to larger ones, indicating 
that the small arteries and arterioles have the highest flow resistance.  This reduction in flow rate for 
smaller vessels is beneficial for the exchange of oxygen to the tissues and organs.  
 
   
  
  
 Equation 1.2 
 
Equation 1.2 illustrates that the resistance is mainly dependent on vessel radius, which is 
controlled by local changes in tissue metabolite concentration or the sympathetic and parasympathetic 
systems
 7
. Blood vessels can constrict or dilate in order to regulate blood pressure, alter blood flow within 
organs, and distribute blood volume in the body
 7
. For example, if a muscle is activated due to exercise, it 
will have a higher metabolic demand and release vasoactive metabolites; therefore, the blood vessels will 
dilate to increase blood flow into the region. In order for this increase in blood flow to occur, the arterial 
pressure must be maintained. This is achieved during exercise by increasing cardiac output, the amount of 
blood ejected per minute, and by constricting the blood vessels going to other organs or muscles that do not 
require an increase in blood flow
 7
. A similar concept occurs when a person stands up and experiences the 
effects of gravity that draws the blood into the legs. When a person stands, heart rate increases and blood 
vessels constrict to maintain a normal blood pressure and to prevent pooling of blood in the legs
 7
.  
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Figure 1.2 shows the mean pressure in the various constituents of the circulatory system, ranging 
from the aorta to the vena cava (the largest vein, which feeds the right atrium) and illustrates the flow of 
blood throughout the body. Blood pressure is highest in the aorta and decreases as the blood moves further 
away from the heart
 7
. The pressure decreases in the aorta and arteries primarily due to simple viscous 
losses
 7
. As blood flows into the smaller arteries and the arterioles it experiences the largest pressure drop 
(approximately 50 to 70%) due to the increased resistance from the decrease in vessel diameter, as well as 
increased compliance (capacitance) of the smaller vessels
 7
. The pressure continues to decrease as the blood 
moves into the capillaries, and then onto the venules and veins. However, this decrease is not nearly as 
great, as shown in Figure 1.2, due to the low resistance of the veins
 7
.  
 
Figure 1.2: Graph depicting the distribution of pressures and volumes in 
the systemic circulation (data obtained from Klabunde
 7
) 
Figure 1.2 also illustrates the percentage of the blood volume stored in each stage of the 
circulatory system.  The walls of the veins are extremely compliant when compared to the more rigid walls 
of arteries, and therefore are able to expand and store larger volumes of blood. This compliance leads to the 
veins acting as capacitors, storing roughly 60 to 80% of the total blood volume. The larger veins have less 
compliance and therefore will store smaller volumes of blood hence the dramatic decrease in blood storage 
for the vena cava. This figure shows that the rigid arteries are subject to large pressures, but store very little 
of the total blood volume (low compliance). In contrast, the veins have a large capacitive effect, with 
volume changing drastically given a relatively small pressure.   
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1.1.2   Anatomy of the Lower Leg  
The specific lower leg anatomy, including the number and location of the various blood vessels, 
varies from person to person; however, there are several main vessels present in virtually all people. The 
main arteries of the calf are shown in Figure 1.3A and include the anterior tibial, posterior tibial, and 
peroneal (fibular) artery. These three arteries branch off of the popliteal artery, which is the main trunk 
supplying the calf. 
There are three categories of veins within the lower leg: the superficial veins, which are near the 
surface, the deep veins residing near the bone, and perforating veins, which connect the other two. The role 
of superficial veins is to act as a conduit, delivering blood collected from the capillaries and venules to the 
deep vein system through junctions and perforating veins
 10
. The main superficial veins of the lower leg are 
the small saphenous vein and the great saphenous vein (Figure 1.3B). The purpose of the deep veins is to 
transport blood to the vena cava, which connects back to the heart. The three major vessels of the deep 
venous system that empty into the popliteal vein include the anterior tibial vein, the posterior tibial vein, 
and the peroneal (fibular) vein (Figure 1.3B). The main deep veins run parallel to the main arteries.  
Finally, perforating veins link the superficial and deep vein systems and act as a “check-valve” between the 
two systems
 11
. Perforating veins are activated by the muscle pump (to be described in the following 
section) and help maintain even and efficient ejection of blood from the leg
 11
. Each perforating vein 
contains at least two valves in order to prevent backflow from the deep system into the superficial system
 
11
.  
  
Figure 1.3: A posterior illustration of the main arteries (A) and veins (B) of 
the lower leg (adapted from Anatomy and Physiology Note Summaries
 12
) 
(A) (B) 
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1.1.3 Muscle pump  
In order to expel the volume of blood stored in the deep and superficial veins as seen in Figure 1.2, 
the body has a physiological mechanism, known as the calf muscle pump, which aids in the return of blood 
to the heart. The main muscles of the calf are the gastrocnemius and soleus muscles.  As shown in Figure 
1.4, these muscles surround the deep veins and compress them during muscle contraction to aid in venous 
return. The muscle pump acts to compress and release the deep veins and therefore creates pressure 
gradients that encourage the return of blood to the heart, see Figure 1.5
 13
. The veins are divided into 
sections due to the presence of valves. When the muscle contracts, the pressure within the vein segment 
increases, causing the upstream valves to close and downstream valves to open, see Figure 1.6A
 7
. When 
the muscle relaxes, a pressure gradient exists that draws blood from the superficial system and opens the 
upstream valves allowing the vein segment to fill with blood, as illustrated in Figure 1.6B
 7
.  During 
contraction, the pressure in the deep veins is very high (roughly 200 mmHg), while the pressure in the 
superficial veins is low (approximately 30 mmHg)
 14
. The deep veins can sustain such high pressures during 
contraction because the pressure from the muscle does not allow the vein to dilate. During relaxation, the 
pressure in the deep veins is between 0 and 10 mmHg, and the pressure in the superficial system is around 
90 mmHg resulting in filling of the deep veins from the superficial vein network
 14
.  
 
Figure 1.4:  An illustration of the main muscles of the calf 
(adapted from Floota
 15
) 
 
 
 
 
 
 7 
 
Figure 1.5: An illustration of the mechanisms of the muscle pump 
showing the muscles relaxed and valves closed (A) and the muscles 
contracted with the valves opened (B) (adapted from CNX Anatomy 
and Physiology
 16
) 
 
 
  
Figure 1.6: An illustration of the direction of blood flow during contraction (A) and 
relaxation (B) of the muscle (adapted from YouTube
 17
) 
1.1.4 Passive Compression  
1.1.4.1 Background of Passive Compression   
Passive compression is used to treat venous insufficiencies that reduce the effectiveness of the 
muscle pump, mainly varicose veins, deep vein thrombosis, and chronic venous insufficiency
 18
. These 
conditions are typically found in older populations, pregnant women, or persons who sit for extended 
periods of time. In each of these populations there is a higher risk of blood pooling in the legs. Varicose 
 
(A) (B) 
 (A)  (B) 
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veins occur when the veins become twisted and enlarged and fail to function properly leading to blood 
collecting in the legs, which can lead to blood clots or ulcers in the body
 19
. Deep vein thrombosis is a 
condition whereby blood clots form in the deep veins, which can lead to a pulmonary embolism should the 
thrombosis dislodge and be carried through the circulatory system
 20
. Lastly, chronic venous insufficiency 
is a condition where the valves located in the veins do not function properly, therefore allowing blood to 
pool and collect in the veins
 21
. Compression helps reduce the effects of these conditions and move blood 
more efficiently by preventing swelling of the leg and reducing the chance that blood will pool and clot
 19, 
20
.  
Passive compression is generally applied to the leg in the form of a sock or stocking that can go to 
the knee or thigh depending on the degree of compression required. These socks have a compression 
pattern that provides pressure decreasing from distal to proximal (i.e. high pressure at the ankle, lower 
pressure at the knee or thigh). This compression pattern is referred to as graduated compression and acts to 
enhance the pressure gradient that exists in the veins to increase venous return. An illustration of the 
change in applied pressure from the garment is shown in Figure 1.7. The exact mechanisms by which 
passive compression works are not fully understood, however two methods are generally accepted. The 
first suggests that compression reduces and helps prevent swelling by increasing the pressure in tissues 
under the skin, reducing excess fluid leakage from the capillaries, and increasing absorption of tissue fluid 
by the capillaries and lymphatic vessels
 18
. The second method suggests that compression helps control the 
diameter of the superficial veins, which decreases the risk of pooling and facilitates the return of blood to 
the heart
 18
.   
 
Figure 1.7: An illustration of the applied pressure to the leg from 
the GCS (adapted from VenaCureEVLT
 22
) 
The strength of the compression garments varies based on the intended use, and can range from 
values of 8 mmHg to 50 mmHg or higher. For compression higher than approximately 25 mmHg, a 
prescription from a physician is required. The lower pressure range (8 to 30 mmHg) is utilized for minor to 
moderate varicose veins and swelling, during pregnancy, after surgery, or in exercise applications
 18
. Higher 
 Decreasing  
Pressure 
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pressure (above 30 mmHg) is used for chronic venous insufficiency, deep vein thrombosis, severe swelling 
or varicose veins, and other serious medical issues
 18
.  
Precise measurements of the patient’s leg dimensions (ankle, calf, and thigh circumference and 
calf and leg length) are required in order to ensure the proper sock fit.  The proper fit is extremely 
important, as the applied pressure from the socks can vary when the socks are not fitted or worn properly
 23
. 
Blood flow can be significantly restricted by even a slight increase in the pressure exerted by the sock
 23
. 
An increase in applied pressure above the recommended level could cause occlusion of the superficial or 
deep veins, making the socks ineffective for treating venous diseases.  
Passive compression has been proven effective qualitatively in preventing and minimizing the 
severity of venous insufficiencies
 23-25
, however there are limited results in terms of quantitative data. 
Contradictory results exist on the effect of compression on the structural and functional parts of the vein. A 
detailed literature survey of the impact of compression on physiological performance metrics, including 
blood flow velocity and vessel diameters, indicates that there is currently disagreement amongst researchers 
employing different measurement and analysis techniques. Magnetic Resonance Imaging (MRI) studies
 3, 4, 
26, 27
 in conjunction with Finite Element Analysis (FEA)
 28-33
 have suggested that while pressure decreases 
with depth in the leg due to external compression, the superficial vein diameters remain constant and the 
deep vein diameters decrease. Since both types of veins have nominally the same material properties, these 
two statements appear to be in contradiction. Ultrasound studies
 5, 34, 35
 suggest that, in fact, the deep veins 
compress less due to the attenuation of the compressive stress with depth, which is more palatable. The vast 
majority of these papers do not, however, clearly indicate relevant factors, such as leg position with respect 
to the heart, leg muscle activation, or changes in body position.  Each of these factors can significantly 
affect the behavior of the vasculature and hence diameters and blood flow. Therefore, it is extremely 
important to know them in order to make a fair comparison between the results of the MRI, FEA, and 
ultrasound studies. 
1.1.4.2 Extension to Exercise  
The use of passive compression has been extended from a clinical treatment to an elective tool 
used by healthy individuals in an attempt to improve exercise performance. The rationale being that GCS 
will enhance the muscle pump, increase venous return, and decrease pooling in the legs, leading to 
increased cardiac efficiency and therefore stronger performance
 36
. During exercise the heart works to 
maintain cardiac output in order to supply the muscles with a sufficient amount of oxygen rich blood. 
Cardiac output (CO) is calculated, as shown in Equation 1.3, from the product of heart rate (HR) and stroke 
volume (SV), the latter of which is the amount of blood pumped out of the heart during each contraction.  
 
    
 
   
      
    
   
     
  
    
        
 
  
   
        Equation 1.3 
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With an increase in the amount of blood returning to the heart, heart rate could potentially 
decrease as stroke volume increases, while still maintaining cardiac output. There is also the potential for 
cardiac output to rise due to an increase in stroke volume while maintaining a constant heart rate.  Higher 
cardiac output would mean that more blood can be supplied to the exercising muscles and therefore 
increase the amount of oxygen the muscle receives. Muscles use oxygen to break down glucose and create 
fuel in the form of adenosine triphosphate (ATP)
 37
. During exercise, the oxygen that reaches the working 
muscle is immediately converting glucose into energy
 37
. When the body cannot maintain the oxygen 
demand, the muscles begin to convert glucose into lactic acid as a rapid, but inefficient mechanism to 
produce ATP
 37
. The body can only sustain higher intensities of anaerobic exercise for a short time period 
before the metabolites accumulate and fatigue sets in
 37
.  During recovery, the muscles require oxygen to 
replenish pre-exercise ATP levels in the muscle and help the liver break down lactic acid
 37
. An increase in 
oxygen delivery therefore has the potential to enhance muscle performance and aid in faster recovery time
 
36
.  
There is however, conflicting evidence for the effectiveness of compression on improving central 
and localized hemodynamics in a healthy population
 1, 2
. When investigating the effects on running, the 
findings are inconclusive as to whether compression is beneficial. Inconsistency in the findings is reported 
for various types of exercise (i.e. sprinting, jumping, biking, or long distance running). One study tested 12 
endurance-trained athletes and performed a time limit test with the athletes running at 105% of a recent 10 
km race pace. It was found that time to exhaustion increased (337 vs. 387 seconds) and peak oxygen uptake 
was lowered (approximately 62 vs. 53 ml/kgmin) when wearing GCS
38
. Another study looking at 21 
moderately trained runners found that time under load (35.03 vs. 36.44 min) and total work (399 vs. 422 
KJ) was increased with GCS and that running performance was improved at different metabolic thresholds
 
39
. Testing compression during normal daily activity in 21 healthy females found that GCS aided in 
preserving lower leg venous calibre and tone through the veins and lowered calf circumference by 5.2± 7.0 
mm
 40
. Other studies however find no changes in physiological variables with the addition of compression
 1, 
5, 36, 41
. For example the effect of compression on the popliteal vein was investigated in 25 healthy males at 
rest and during ankle exercise and the results found no changes in popliteal vein blood velocity, diameter, 
or volumetric blood flow
 5
. 
The majority of studies use individual perception to quantify the degree of muscle soreness as an 
indicator of the effect of compression on recovery. Several studies have found that participants feel they 
experience a decrease in muscle soreness with compression
 1
. However, in studies where other indicators 
are used, creatine and lactate levels typically experience no change making it difficult to differentiate if the 
effect is from the GCS or due to the placebo effect
 1
. For example, one study looked at the effect of 
compression on recovery for 40 competitive runners after a 56 km race and found reduced swelling, lower 
lactate levels, decrease in muscle damage (lower myoglobin levels in blood), and less perceived pain 
immediately after exercise and up to 48 hours following running
 42
.  Another study testing trained runners 
 11 
for 40 minutes of running found no change in blood lactate and no impact on muscle function or soreness
 
36
.  
The existence of conflicting evidence could be in part due to the hypothesis that a healthy 
population may need an accommodation period to experience the benefits of GCS or due to the various 
testing regiments
 1, 38
. Each study uses different exercise tasks at various intensities and durations. The 
study populations vary from subjects with normal, moderately active lifestyles to highly trained athletes. 
The applied pressure from the compression socks varies as well as the locations where the compression is 
applied (i.e. calf, thigh, full body). Finally, the extent to which the compression is applied during recovery 
varies from study to study. All of these factors make it difficult to draw concrete conclusions on the effect 
of compression during exercise and recovery in healthy populations.  
1.2  Study Objectives  
Although there have been several studies published on the effectiveness of passive compression in 
healthy populations, there are discrepancies as to whether they are beneficial for enhancing performance 
and recovery time. Due to the variation in experimental methods in current research protocols, concrete 
conclusions cannot be accurately drawn. The aim of this study is to complete a set of controlled 
experiments measuring a variety of physiological factors in an effort to determine the effect of passive 
compression on a healthy population. Included is the impact of passive compression on peripheral and 
central hemodynamics at rest and during exercise in a healthy population. For peripheral hemodynamics, 
the main variables to be investigated include; vessel diameter, blood velocity, muscle activity, oxygen 
delivery and uptake, and the applied pressure on the lower limb from the GCS. For central hemodynamics, 
the effect of external compression on heart rate, cardiac output, and blood pressure will be studied. In order 
to determine the effect of external compression on hemodynamics, the compression study will be compared 
to a baseline study where no compression is utilized. Investigating the impact of compression during rest, 
and before and after exercise, will isolate the effect of external compression from the underlying 
mechanisms of vascular behaviour in the standing position. During exercise, the baseline study will 
determine the impact of the muscle pump on hemodynamic behaviour, and with the addition of 
compression, the compound effect of passive compression with muscle pump activity will be resolved.  
 
One key aspect of this study is that the applied pressure on the lower leg due the GCS will be 
measured and mapped in order to quantify the actual pressure applied to the leg. Previous research studies 
rarely report on measurements of the compressive force of the passive compression on the legs
 1
. This is 
extremely important as the pressure distribution can vary from the manufacturer reported operational 
pressure based on leg geometry and sock application. This study will be compared to the conflicting 
evidence that exists from prior studies on the effectiveness of compression on improving hemodynamics in 
a healthy population with the hope that additional attention paid to the actual loading from the sock will aid 
in ending the debate on GCS effectiveness.  
 12 
It is hypothesized that the addition of the GCS will enhance venous return, and therefore stroke 
volume, by helping to amplify the affect of the muscle pump. It is also thought that the GCS will decrease 
blood volume in the leg during the entire protocol since the prescribed clinical function of the GCS is to 
constrict the calf volume and help prevent blood pooling in the legs. It is believed that investigating plantar 
flexion exercise in the calf region will lead to no significant changes in central hemodynamics as only a 
small muscle mass is recruited to complete the task and therefore any local changes in the legs are not 
anticipated to have an impact on the central system. Furthermore, for muscle activity it is hypothesized that 
the participants will require less muscle activation on the second day of testing as they become more 
familiar with the protocol and can complete the task with more fluent motions and potentially less muscle 
recruitment. Finally, it is believed that the amount of muscle activation required during exercise will be tied 
to the subject’s lifestyle with the rationale being that those subjects that exercise frequently will be able to 
complete the task more easily and require less muscle recruitment than those who exercise infrequently.  
This thesis is organized as follows: the experimental methods are discussed in Chapter 2; the 
results and discussion are presented in Chapter 3; and the conclusions are made in Chapter 4.  
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Chapter 2 
Experimental Methods 
This chapter details the experimental methods, procedures, and equipment used to investigate the 
effect of external compression on central and peripheral hemodynamics. In addition, this chapter will detail 
the data reduction and analysis methods employed. 
2.1    Overview of the Experimental Procedure 
The experimental protocol investigated the effect of external compression on hemodynamics 
during rest and exercise for two conditions; wearing graduated compression socks (GCS) and not wearing 
graduated compression socks (NGCS). The testing began with a short rest period, followed by plantar 
flexion (calf raise) exercises, and finished with a second rest period. Initially, walking was selected as the 
exercise to investigate since it is an exercise completed by the population on a daily basis. However, 
walking could not be tested due to the limitations of using ultrasound to obtain muscle blood flow. 
Electromyography (EMG) tests comparing calf raises to walking illustrated that the total muscle activation 
of the calf during plantar flexion was similar to that during walking and therefore plantar flexion was 
considered an appropriate substitute. Results of the EMG study can be found in Appendix A.  
Test participants reported to the lab on two occasions with a minimum of 48 hours between testing 
periods to evaluate repeatability. The order of the experiments was counterbalanced between subjects in 
order to determine if the order in which they completed the NGCS and GCS tests was relevant. That is, 
each participant completed the series of tests in the opposite order on the second day of testing (i.e. starting 
with the GCS condition on the first day of testing and starting with the NGCS condition on the second day, 
for instance). Furthermore, the experiment was designed so that half of the participants began with the GCS 
test on the first day of testing, and the other half began with the NGCS test on the first day.  The 
experimental protocol for this study received clearance from the University of Waterloo Research Ethics 
Committee (ORE #19454). 
To investigate the effect of external compression on a global level in the cardiovascular system, 
HR, systolic blood pressure (SBP), diastolic blood pressure (DBP), and CO were measured. It was 
hypothesized that the addition of external compression to the lower extremities would enhance venous 
return to the heart and thus enhance SV. As mentioned in Chapter 1 if there is an increase in SV then there 
is potential for cardiac output to increase while heart rate is maintained, or there is potential for heart rate to 
decrease while cardiac output is maintained. It is of interest to see how SBP and DBP respond to changes in 
other central variables (i.e. HR and CO) due to the negative feedback mechanisms that help to regulate 
blood pressure. Changes in blood pressure would also provide insight into the resistance of the vessels in 
the circulatory system and if there is a significant change when the GCS are worn.  
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To investigate the hypothesis that GCS would enhance venous return at the local level in the lower 
leg, blood velocity, vessel diameter, muscle activity, muscle oxygenation, and applied pressure were 
measured. Blood velocity is important to determine the speed at which blood is returning to the heart and if 
the speed increased with the addition of the sock. Ideally this would be measured in the popliteal vein, as it 
is the conduit through which blood from the lower legs travels back to the heart. However, due to the low 
flow of blood in the veins it is difficult to capture using Doppler ultrasound and tends to get filtered out 
with noise from the system. The experimental uncertainty becomes too high when measuring the velocity 
of blood in the vein and therefore flow in the popliteal artery was obtained instead. Since the vascular tree 
is a closed system and this study focuses on a healthy population where blood pooling in the legs is not 
considered to be an issue, the information obtained from the arterial side should give a direct understanding 
of what was occurring on the venous side and returning to the heart. Popliteal arterial diameter was 
measured to determine if the vessel dilated or constricted during the testing protocol, prompting a change in 
blood flow, when the GCS was applied. Monitoring muscle activity provided details into the amount of 
muscle activation required to complete the exercise task with and without the GCS. If the muscle activation 
was similar for the NGCS and GCS cases, then it could be concluded that the participant was completing 
the same task each time and that the GCS have no effect on muscle activation. Muscle oxygenation was of 
interest since an increase in SV would imply that more blood is being delivered to the exercising muscles 
and hence increasing the amount of oxygen the muscle receives. Finally the applied pressure from the GCS 
was recorded to determine the additional change in pressure aiding venous return to the heart. Continuously 
measuring these global and local variables provided insight into how the body responds to the addition of 
the GCS and if the effects were beneficial for a healthy population.  
2.2    Participants  
Twelve healthy volunteers (7 male, 5 female, age 27.3 ± 6.40 years, body mass 73.0 ± 16.9 kg) 
participated in the study. All volunteers were instructed to avoid large meals two hours prior to testing, to 
refrain from heavy exercise 24 hours before testing, and to not consume caffeinated beverages 12 hours 
prior to testing.  Participants received an overview of the protocol from the researchers with the opportunity 
to raise questions or concerns and were made aware of their right to withdraw from the study at any time. 
Each volunteer completed consent and health status forms and a physical activity readiness questionnaire 
(PAR-Q). The health status form included questions about the participant’s exercise habits in order to 
determine their lifestyle. This included asking about the frequency of exercise as well as an explanation of 
the typical exercise performed. The conclusion from the health status forms was that the volunteers had 
sedentary to moderate exercise lifestyles. All forms were reviewed before proceeding with testing and any 
concerns were addressed. The protocol and consent forms are presented in Appendix B. 
2.3     Experimental Protocol 
Upon arrival to the lab, the participant’s height, weight, and calf skinfold (measure of the fat layer 
below the skin) were measured. These measurements were used as inputs into the data collection devices 
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described in the next section. Next, the calf region was cleaned with alcohol and electrodes were placed on 
the leg to attach the EMG to obtain muscle activity information from the gastrocnemius and soleus 
muscles. A maximum voluntary contraction (MVC) test, which is a measure of the maximum tension the 
muscle can hold while completing one calf raise, was then performed. The MVC test was completed each 
day before testing in order to determine the percentage of the MVC that was required to complete the calf 
raise exercise. This normalization by the MVC values for each day provided insight into the muscle 
activation required for each participant to perform the test. Following the MVC test, each participant was 
instructed to complete one calf raise in order to position shoulder blocks to control the calf raise height. 
This ensured the participants completed the same task during each test. After the placement of the shoulder 
blocks, the heart rate monitor was connected to the participant and the Finometer® cuff (see Section 2.4) 
was placed on the middle finger of the left hand. The Finometer® was calibrated and a manual blood 
pressure measurement was taken to verify the value obtained from the Finometer® after calibration. The 
manual blood pressure measurement was repeated prior to the second test each day. 
  Continuing with the experimental set-up, the near-infrared spectroscopy (NIRS) probe (see 
Section 2.4) was attached to the medial head of the gastrocnemius. Calf circumference was then measured 
to determine the proper sock size as per the manufacturers recommended sizing method. Commercially 
available CEP Progressive+ Run Socks were used in this study, which have a manufacturer reported 
operational pressure range of approximately 15 mmHg to 25 mmHg. Next, a total of four air bladders were 
applied to the calf using Band-Aids and medical tape to hold them in place to record the applied pressure. 
Two pressure bladders were placed on both the medial and lateral side of the leg, as shown in Figure 2.1. 
The bladder locations were based off of anatomical landmarks on the knee and ankle. The distance between 
the bladders, d, differed from person to person due to the varying anatomical landmarks. This variation in d 
meant that the same pressure gradient was not applied to each subject’s leg, but instead the change in the 
GCS pressure between d (ΔP) was made equivalent amongst subjects. The ΔP was maintained within 10 ± 
3 mmHg by applying additional pressure at the ankle with tensor bandages as necessary. As previously 
discussed, the pressure applied by the sock varied based on leg geometry and application, the tensor 
bandages were only utilized if a ΔP of 10 ± 3 mmHg was not achieved independently by the GCS.  
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Figure 2.1: Two pressure bladders on both 
the medial and lateral side of the leg (lateral 
side shown). 
If the GCS test was completed first, then after the compression sock had been properly sized and 
the desired ΔP was achieved, the popliteal artery in the right leg was located using echo Doppler 
ultrasound. If the NGCS test was completed first, once the calibration of the Finometer® was completed, 
the process of locating the artery began immediately and the addition of the pressure bladders and external 
compression occurred during a break between testing. The location of the popliteal artery was marked for 
diameter measurements during the testing protocol, as well as for placement of the Doppler ultrasound 
probe that obtained the velocity signal in the popliteal artery. The Doppler ultrasound probe used for 
velocity data was adjusted until a clear velocity signal was obtained from the artery with no contamination 
from the popliteal vein. Finally, a dark cloth was wrapped around the leg, either over the bare calf or on top 
of the sock to ensure no light affected the NIRS measurement device (see Section 2.4). This wrap applied 
no additional pressure to the leg and only served as a cover for the NIRS probe, as confirmed by the in situ 
pressure bladders.  
After the experimental set-up was completed, all measurement locations were recorded for future 
testing and participants sat for 15 minutes with all devices on to allow for stabilization. In between tests, as 
previously mentioned, there was another break (approximately 15 minutes) while the GCS was removed or 
added depending on the order of testing. Once the GCS was applied to the leg, a 10 minute accommodation 
period was used to allow the body to acclimate to the additional pressure
 3, 4
. 
For the testing portion of the protocol, participants initially stood in a natural posture with both 
feet on the ground for a three minute baseline (BL) to allow their bodies to acclimatize to the standing 
position. Next, participants completed a five minute exercise period (EX) in which they completed plantar 
flexion (calf raise) exercises to simulate the activity of the calf muscle during walking. Lastly, participants 
were again asked to stand in a natural posture for a five minute recovery period (REC). The recovery period 
was included to allow the body to return to baseline conditions after the completion of exercise. The total 
Ankle 
Sensor 
Knee 
Sensor 
 Decreasing 
Pressure  
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protocol took 13 minutes to complete, see Figure 2.2. The calf raises were performed at a rate of 20 per 
minute for five minutes to allow the body to come to steady state during exercise. This involved calf raises 
completed with a period of three seconds, as illustrated in Figure 2.3, where participants were instructed to 
raise their ankles for one second (Figure 2.3A), lower their ankles for one second (Figure 2.3B), and relax 
with both feet on the ground for one second (Figure 2.3C). The protocol was then repeated for the opposite 
condition (i.e., NGCS or GCS depending on the first test completed).  
 
Figure 2.2: Exercise Protocol 
 
Figure 2.3: Protocol for plantar flexion exercise completed over a period of three 
seconds. The participant’s raised the ankles over a one second duration (A), 
lowered the ankles over a one second duration (B), and relaxed for one second (C) 
(adapted from Verge Magazine
 43
) 
All measurements were continuously recorded throughout the testing protocol except for diameter 
measurements, which were completed during baseline and recovery conditions only. During exercise, with 
the calf continuously moving it was too difficult to sustain a quality image on the ultrasound, as well as it 
would require an interruption in the collection of velocity data, as the operator would have had to switch 
ultrasound systems for a short period of time. More details on data collection are presented in Section 2.4. 
2.4     Data Collection  
Peripheral and central hemodynamics were monitored using physiological testing equipment, as 
shown in Figure 2.4 and Figure 2.5. All peripheral measurements were performed on the right leg only. 
During the experimental protocol, arterial blood pressure was continuously measured by a 
photoplethysmograph cuff (Finometer, Finapres Medical Systems, Amsterdam, The Netherlands), placed 
on the middle finger of the left hand (Figure 2.5(A)). This device estimated the cardiac stroke volume from 
a finger pressure wave and multiplied SV by heart rate to estimate cardiac output, see Section 2.4.1 for 
   Baseline 
(3 minutes)  
Plantar Flexion Exercise  
(5 minutes)  
Recovery 
(5 minutes)  
(A) (B) (C) 
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more details. Heart rate was calculated from the R-R interval (beat to beat average) obtained from an 
electrocardiogram (ECG) (Pilot 9200, Colin Medical Instruments Corp, San Antonio, Texas, USA) (Figure 
2.5 (C)) described in detail in Section 2.4.2. Concomitantly, peripheral blood flow was obtained by a 4 
MHz Doppler ultrasound probe (Neurovision Doppler Ultrasound, Model 500, Multigon Industries, 
Elmsford, New York, USA) to determine beat-by-beat blood flow velocity in the popliteal artery, the main 
feed artery to the calf muscles (Figure 2.5 (B)), see Section 2.4.3. Vessel diameter was measured using an 
8-12 MHz linear array ultrasound transducer (L14-6s with M5 system, Mindray Medical International 
Limited, Shenzhen, China) described in Section 2.4.3. Muscle activity was measured in the gastrocnemius 
and soleus muscles (calf muscles) using a custom built EMG (Figure 2.5(D)) discussed in Section 2.4.4. 
The EMG signal was processed using a custom MATLAB program (MATLAB, vR2013a, The Mathworks 
Inc., Natick, Massachusetts, USA). Blood pressure, heart rate, blood velocity, and muscle activity were 
sampled at 1000 Hz using a data acquisition system (Powerlab, ADInstruments, Colorado Springs, 
Colorado, USA) and processed using LabChart analysis software (LabChart, v7.2.5, ADInstruments, 
Colorado Springs, Colorado, USA). Muscle oxygenation and blood volume were measured on the 
gastrocnemius medial head using NIRS (PortaLite, Artinis Medical Systems B.V., Elst, The Netherlands) 
and sampled at a rate of 50 Hz; see Section 2.4.5 for more details on the NIRS system. Finally, the pressure 
applied to the calf muscles was determined by a custom-built system consisting of a series of bladders 
placed on the medial and lateral aspect of the calf muscle between the GCS and the skin. The pressure data 
was acquired at a sampling rate of 10 Hz using LabVIEW software (LabVIEW, National Instruments 
Corporation, Austin, Texas, USA).  The acquisition of dynamic pressure measurements allowed for the 
applied pressure to be correlated with physiological measurements. More information on the custom 
pressure system can be found in the Section 2.4.6.  
 
  
Figure 2.4: Peripheral measurement probes 
displayed on leg along with the GCS 
Figure 2.5: Experimental setup including (A) 
Finometer®, (B) Doppler Ultrasound, (C) Colin 
Heart Rate Monitor, (D) EMG 
(B) 
 (A) 
 (D) 
 (C) 
ULTRA-
SOUND 
NIRS 
EMG 
GCS 
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2.4.1 Finometer® 
The Finometer® utilizes photoplethysmography (a method for measuring changes in volume) to 
measure blood pressure and heart rate and predict cardiac output. A photoelectric photoplethysmograph 
cuff is placed on the middle finger of either hand and finger blood pressure is determined using the volume-
clamp method
 44
.  This method measures the volume of the arteries under the finger cuff using a pneumatic 
servo system and aims to dynamically hold that volume constant by measuring the counter pressure in the 
finger cuff during the pulsation
 44
. 
The desired blood pressure measurement is the brachial artery blood pressure, which is 
reconstructed from the finger pressure obtained using an inverse modeling corrector and a height corrector. 
The inverse modeling corrector is a frequency-dependent transfer function that is used to obtain the 
brachial pressure waveform model from the measured finger pressure waveform
 45
. The height corrector is 
used to account for the change in hydrostatic pressure due to the location of the brachial artery compared to 
the finger.  
Once the brachial blood pressure is reconstructed, a “Modelflow” algorithm is used to obtain the 
aortic flow waveform.  The “Modelflow” algorithm is a non-linear model of the aortic input impedance 
consisting of three elements: aortic characteristic impedance, Windkessel arterial compliance, and systemic 
vascular conductance
 44
. The aortic characteristic impedance is the aortic opposition to the pulsatile flow 
from the left ventricle
 45
. The Windkessel arterial compliance is the aortic elastic storing property, and the 
systemic vascular conductance is a measure of the resistance of all vascular beds
 45
. The age, height, and 
weight of the participants are entered into the system in order to help with the accuracy of predicting the 
model inputs
 44
.  Once the aortic flow curve is generated, the area under the curve during systole is 
proportional to the stroke volume
 44
. The stroke volume value is then multiplied by heart rate and an 
estimate of cardiac output is obtained.   
2.4.2 ECG 
The ECG non-invasively monitors and records the electrical activity of the heart through three 
electrodes placed on the chest of the body. Figure 2.6 shows a sample ECG signal for one heartbeat, 
illustrating the important electrical waveforms. A heartbeat begins with an electrical signal originating in 
the sinoatrial node located in the right atrium. The signal then moves through the left and right atria (P 
wave) causing them to contract and move blood to the left and right ventricles. The electrical signal passes 
through the atrioventricular node when moving into the ventricles, slowing the signal to allow time for the 
ventricles to fill.  Once the signal moves out of the atrioventricular node, it moves quickly across the left 
and right ventricles causing them to contract and supply blood to the body and lungs, respectively (QRS 
wave). Finally the ventricles return to their normal state (T wave) and the heart muscle stops contracting, 
allowing the heart to refill with blood. The process is then repeated anywhere from 60 to 100 times a 
minute when a person is at rest
 46
.  
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Figure 2.6: Sample ECG signal for one heartbeat illustrating the 
important waveforms (P wave, QRS wave, and T wave) 
 
2.4.3 Doppler Ultrasound  
Ultrasound utilizes high frequency sound waves and their echoes to obtain both structural and 
functional information. The basic concept of ultrasound is that a transducer converts electrical energy to 
acoustic signals that generate pulses of ultrasound that are sent through the body. The sound pulses travel 
into the body and organ boundaries, and complex tissues produce echoes by reflection or scattering, which 
return back to the transducer. The transducer converts this signal back to an electrical signal. The machine 
calculates the distance from the probe to the tissue or organ using the speed of sound in tissue and the time 
delay between transmission and the return of the echo. The machine displays the distances and intensities 
of the echoes on the screen forming a grey scale image; an example image of the popliteal vein is shown in 
Figure 2.7
 47
.  
 
Figure 2.7: Sample ultrasound image of the popliteal vein 
showing a branch location 
P 
R 
S 
T 
Q 
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Doppler ultrasound is used to determine blood velocity. The sound waves from the transducer 
bounce off the red blood cells within the vessel and the signal is returned to the transducer with a Doppler 
shift. The Doppler shift is the change in observed frequency due to the relative motion of the source and the 
observer
 47
. In this case the Doppler shift occurs twice; the first occurs when the transducer is stationary 
(source) while the blood cells are the moving receivers of the waves (observer), the second is when the 
ultrasound is back-scattered from the moving red blood cells (source) to the transducer (observer)
 47
. The 
Doppler frequency (fd) is calculated by subtracting the transmitted frequency (ft) from the received 
frequency (fr) as shown in Equation 2.1
 47
. 
 
         
Equation 2.1 
 
The velocity (v) can then be calculated based off of this shift as shown in Equation 2.2; where c is 
the speed of sound in tissue (1540 m/s) and   is the angle of insonation, which is defined as the angle 
between the flow and ultrasound beam as illustrated in Figure 2.8
 47
. The angle of insonation is extremely 
important as when the angle is 90° the cosine value is 0 and no Doppler shift will be detected, when the 
angle is 0°, the cosine value is 1 and the maximum Doppler shift is detected
 47
. Therefore it is important to 
know the angle of insonation in order to determine which component of velocity the transducer is 
receiving. Finally, the Doppler shift frequencies end up in the audible range (20 Hz to 20 kHz) so the user 
can hear the signal while using the ultrasound, which helps in operating the system and locating the best 
velocity signal
 47
. 
 
  
   
       
 Equation 2.2 
 
 
Figure 2.8: Illustration of Doppler ultrasound physics 
(adapted from Thrush et al.
 47
) 
Transmitted Frequency  
 Received Freq. 
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2.4.4 EMG 
EMG measures the electrical voltage generated in the skeletal muscle during contraction, 
representing neuromuscular activity
 48
. The functional unit of a muscle contraction is a motor unit
 49
. A 
motor unit consists of a group of skeletal muscle fibers and the motor neuron that controls them
 6
. A motor 
neuron is a nerve cell that, directly or indirectly, controls the movement of muscles
 6
. Skeletal muscle fibers 
contract when the action potentials (rapid and uniform electrical signals conducted along the membrane of 
a muscle fiber) of the motor nerve reach a depolarization threshold
 6, 49
. The depolarization, which is a 
decrease in the membrane potential of a cell, spreads through the membrane of the active muscle creating 
an electromagnetic field where the potential is measured as a voltage
 6, 49
. The depolarization is a muscle 
action potential (MAP) and the motor unit action potential is the sum of the individual MAPs for all of the 
skeletal muscle fibers in a motor unit
 49
. The EMG signal is therefore the summation of the motor unit 
action potentials in the location where the electrodes are placed on the surface of the skin
 49
. Each site 
where muscle activity is of interest requires two electrodes so that the voltage waveform recorded is the 
difference in the potential between two electrodes
 49
. MAPs occur at random intervals so at any moment the 
EMG signal can be positive or negative
 48
. The electrical signal obtained is amplified and can be processed 
in several ways (e.g., linear envelope, half-wave rectification, full-wave rectification, root mean square, 
integrated EMG, or frequency analysis
 49
). Figure 2.9 shows an EMG signal obtained from the medial head 
of the gastrocnemius muscle for two contractions of the calf muscle. Figure 2.9A displays the raw 
amplified signal obtained from the electrodes, and Figure 2.9B illustrates an example of a signal that has 
been processed using full-wave rectification (taking the absolute value of the whole signal) and linear 
envelope (using a low-pass filter on the full-wave rectified signal)
 49
.  
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Figure 2.9: A sample EMG signal for two calf contractions showing 
the raw amplified signal (A) and the processed signal (B) using full-
wave rectification and taking the linear envelope.  
2.4.5 NIRS 
NIRS provides the ability to measure oxygen binding to hemoglobin by studying the interaction of 
light with tissue in the near infrared spectrum (700-1300 nm)
 50
. Tissues have good transparency for light in 
this spectrum and therefore it is possible to transmit photons through the muscle for monitoring hemoglobin 
levels
 50
. Hemoglobin contains chromophores, which are the portion of molecules that generate colour 
when they absorb certain wavelengths of light. The main principles of NIRS are therefore that light is 
emitted from the NIRS source, then absorbed by chromophores in the hemoglobin, and a new wave 
(A) 
(B) 
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emission is generated
 51
. The NIRS device captures the new light generated and calculates the optical 
density for each sample
 51
. Lastly, from the optical density values, the changes in oxyhemoglobin (O2Hb) 
and deoxyhemoglobin (HHb) are calculated
 51
.  
The concept of NIRS is based on the Lambert-Beer law shown in Equation 2.3; where OD (λ) is 
the optical density of the tissue, ε(λ) is the absorption coefficient (mM-1cm-1), C is the concentration of the 
chromophore (mM),  L is the distance between light entry and exit point and λ is the wavelength used (nm). 
Equation 2.3 also contains a dimensionless pathlength factor (DPF) to account for an increase in the optical 
pathlength due to scattering in the tissue. The value of DPF used in this study was 5.84 for an adult calf. 
Finally, the OD (λ)r term represents the oxygen independent losses due to scattering in the tissues. It is 
assumed that this value remains constant during measurements and therefore a change in optical density 
(ΔOD (λ)) is converted to a change in concentration (ΔC) as shown in Equation 2.4 50. 
  
                          
 
Equation 2.3 
 
   
      
          
 
 
Equation 2.4 
 
Equation 2.4 is valid for a medium with one chromophore, however in tissues there are at least 
two oxygen dependent chromophores present leading to a set of linear equations that is solved by an 
algorithm in the NIRS software
 50
.  The Portalite system used in this study uses two wavelengths (760 nm 
and 850 nm) to obtain information about the two main components of hemoglobin: O2Hb and HHb. 
Moreover, NIRS provides information about the total blood volume in the tissue (total hemoglobin, tHb) 
and the absolute oxygenated hemoglobin percentage (TSI)
 50
. Two wavelengths are required due to 
different absorption spectra for O2Hb and HHb
 50
. Finally, NIRS measurements can only provide relative 
values for the variables of interest and therefore a baseline condition is required for comparison purposes, 
for this study the baseline used was the initial three minutes of quiet standing before beginning exercise
 51
.  
2.4.6 Pressure System  
A custom system was designed and built to measure the pressure applied to the leg by the GCS. 
The pressure measuring system consists of four Omega PX309 (0-2 PSI) pressure transducers, 16 PicoPress 
pressure sensors, and 19 solenoid valves. The pressure sensing elements are a series of air bladders that are 
placed directly between the skin and the GCS. The system is separated into four sections, as illustrated in 
Figure 2.10, to allow for the pressure to be measured in four locations simultaneously. Figure 2.10 also 
shows that each section is separated from the others by a solenoid valve and contains a pressure transducer, 
four pressure sensors, and four solenoid valves. Figure 2.11 is an image of the system and shows the 
solenoids and the pressure sensors, which are connected to the transducers via flexible plastic tubing. 
 25 
Initially, all of the solenoids are opened and a small pressure (< 1 mmHg) is introduced into the system to 
inflate the pressure sensors. Once all 16 pressure sensors are partially inflated, the three solenoids, which 
separate the four sections from each other, close. To measure the pressure applied to any sensor, the 
solenoid valve placed between the pressure sensor and transducer is opened, while the other three solenoids 
in the section remain closed. This allows the transducer to measure only the pressure applied to the selected 
sensor. Cycling through the four solenoid valves in a section allows the four sensors to apply their pressure 
to the transducer in turn. Since continuous monitoring of the applied pressure from the GCS was required 
for this experiment, only one pressure sensor from each of the four sections was employed. Information 
regarding the calibration and validation of the pressure system can be found in Appendix C
 52
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10: Schematic of the pressure sensor system (adapted from Beentjes
 52
) 
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Figure 2.11: An image of the pressure sensor system showing the 19 solenoids and the 16 
pressure sensors (adapted from Beentjes
 52
) 
2.5    Data Analysis  
For central variables, the averages over the entire BL, EX, and REC conditions were computed. 
Before averages were calculated, the raw data for cardiac output and blood pressure were shifted by one 
second to account for the delay in the analog signal from the Finometer® to the data acquisition system
 44
. 
Also, the beat-to-beat average for heart rate was calculated from the R-R intervals obtained from the ECG 
signal. A shorter averaging time of 180 seconds was used for one subject due to noise in the heart rate 
signal thought to be caused by the placement of the electrodes that led to interruption in the signal due to 
movement of the chest from breathing. This occurred for only one of the two testing days. Figure 2.12 
shows an example of the signal corrupted by the presumed ECG motion compared to a normal heart rate 
signal. A second subject had noise in the blood pressure and cardiac output signals due to issues with the 
Finometer® during one of the days of testing. The issues are thought to be due to the machine not being 
able to maintain a continuous signal for finger pressure due to cold hands of the subject; therefore, a shorter 
period of 112 seconds was used for computing the average values for that subject. Shorter averaging times 
were also required for one subject during recovery for both days (108 seconds for day 1 and 248 seconds 
for day 2) again due to the same issue with the Finometer®. Figure 2.13 illustrates an example of the 
Finometer® issues by showing a comparison between the interrupted blood pressure waveform (Figure 
2.13A) and a typical blood pressure waveform (Figure 2.13B), which only has an interruption in the signal 
when the calibration occurs.  
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Figure 2.12: Illustration of issues with the heart rate signal for one subject showing a 
comparison between the interrupted heart rate signal (A) due to the placement of 
electrodes, and a typical ECG signal (B) 
 
 
 
Figure 2.13: Illustration of issues with Finometer® for one subject showing a 
comparison between the interrupted blood pressure waveform (A) thought to be due 
to the cold hands of the subject, and a typical blood pressure waveform (B), which 
only has an interruption in the signal when calibration occurs 
For the blood velocity (v) data obtained from the Doppler ultrasound, a low pass digital filter of 10 
Hz was applied to the signal as demonstrated in Figure 2.14. The jagged nature of Figure 2.14A illustrates 
that the data acquisition system had a higher sampling rate than the Doppler ultrasound, leading to the 
sampling and holding pattern in the signal. The data acquisition system sampled at a rate of 1000 Hz 
compared to the Doppler ultrasound which had a sampling rate within the range of 140 Hz to 160 Hz. The 
low pass filter of 10Hz, as illustrated in Figure 2.14B, was selected as it removed noise from the signal and 
only allowed the frequencies of the physiological signal of interest to pass through. Furthermore, the data 
was adjusted to account for the typical insonation angle (see Section 2.4.3) of the popliteal artery of 60° as 
shown in Equation 2.5. This angle of insonation was used for the entire study population after verifying that 
all subject’s popliteal artery was positioned at an angle of approximately 60°. The mean of the corrected 
velocity (PBVmean) signal was used in further analysis.  
(A) 
(B) 
(A) 
(B) 
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Figure 2.14: Comparison of the raw velocity signal obtained from the popliteal artery (A) 
and the processed signal when a low pass filter is used with a cut off frequency of 10 Hz (B)  
 
 
           
    
     
 
 
Equation 2.5 
 
Due to the fact that the ultrasound probe had to be manually held against the subject’s leg 
throughout the entire protocol, it was difficult to obtain a clear signal over the entire testing period. 
Therefore, the averages for one minute during BL, steady state EX, and REC were used to determine the 
effect of external compression. The criteria for selecting the minute where the average was taken for each 
condition involved ensuring there was no obvious contamination in the velocity signal from the popliteal 
vein or due to operator movements as illustrated in Figure 2.15. It can be seen in Figure 2.15A that when 
the popliteal vein is also insonated there is a stronger negative velocity, which would affect the average 
compared to Figure 2.15B where only signal from the popliteal artery is recorded. In some situations it was 
not possible to obtain a clean signal for one minute for all participants. For the baseline condition, four 
subjects had time average durations that ranged from 40 to 48 seconds for one day of testing, as these were 
the longest spans of unadulterated signal. For exercise, one subject required that all test averages be 
shortened (between 38 and 45 seconds) and two other subjects had averages of 36 seconds and 45 seconds 
for one day during one test. Finally, for recovery, one subject required a 37 second average on one day for 
one test.  
  
Figure 2.15: Comparison of velocity waveforms during baseline condition showing a 
waveform disrupted due to venous activity  (A) and a clean waveform (B) 
The time required for each subject to return to a PBVmean value of 50 % above their average 
baseline velocity was analyzed to determine the time to recovery for the NGCS and GCS. This time was 
investigated to determine if the GCS could aid in a faster hemodynamic recovery following exercise. A 
beat-to-beat average of PBVmean was used and the data was smoothed using a moving average to minimize 
Interruption 
from venous 
signal 
(A) (B) 
(B) (A) 
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variation between heartbeats. Moving averages of various degrees were tested, as illustrated in Figure 2.17 
for one subject. A moving average consisting of seven data points was used as it was determined, 
qualitatively, to smooth the data best without significantly changing the values. The moving average of 
seven points had fewer outliers when compared to the averages involving fewer points and a more 
consistent trend. Visual comparisons between moving averages of seven and 10 points were not deemed 
significant and therefore seven points was selected as the ideal value. The time to recovery was selected 
when subjects steadily maintained a value of 50% above the average BL velocity or below.  
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Figure 2.16: Comparison of raw data to moving averages involving varying data points (A: 3 points, 
B: 5 points, C: 7 points, D: 10 points) 
Popliteal artery diameter (PAD) was computed from the diastolic diameter, as this portion of the 
cardiac cycle has been proven to provide the most stable diameter image for analysis
 53
. The average of 
three measurements was taken. Mean flow rate in the popliteal artery (PBFmean) was calculated using 
Equation 2.6
 54
. Since the diameter was only measured during baseline and recovery conditions, the 
diameter obtained during the baseline condition was used to calculate PBFmean for the exercise condition. 
Mean arterial pressure (MAP), an estimation of the average blood pressure of an individual, was calculated 
based on SBP and DBP as shown in Equation 2.7
 7
. 
  
        
  
   
          
  
 
     
       
 
 
 
    
 
   
  
 
 
Equation 2.6 
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Equation 2.7 
 
 
Stroke volume was computed using Equation 2.8
 55
. Total peripheral resistance (TPR), a measure 
of the overall resistance of the peripheral circulation blood flow, was calculated from Equation 2.9
 55
. 
Lastly, muscle perfusion pressure (MPP) was estimated using Equation 2.10
 54
, which utilizes the distance 
from the heart to the calf muscle (DHC) to predict the pressure of blood being delivered to the calf muscle.   
  
   
  
    
  
   
 
   
 
        
      
  
 
   
 
Equation 2.8 
  
    
    
     
  
          
    
 
   
 
 
Equation 2.9 
  
                    
        
     
  
    
 
  
 
Equation 2.10 
For NIRS data, tHb, O2Hb, and HHb were analyzed. In order to determine the effects of external 
compression on muscle oxygenation during exercise, the difference from the baseline condition must be 
determined. Therefore the mean of the last 30 seconds of baseline for each variable was subtracted from the 
values obtained during exercise. To determine the effect of compression during recovery, the difference 
from the exercise condition was investigated. The averages of the last minute of exercise and recovery were 
analyzed as the majority of participants had reached steady state by these times. The overall average of 
each variable for all participants was analyzed for both days of testing. Figure 2.17 shows an example of 
the raw data obtained for the tHb variable and the locations where the averages were calculated for each 
condition.  
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Figure 2.17: Illustration of the time spans over which average values were calculated for NIRS 
analysis during BL, EX, and REC 
The EMG signal was processed using full wave rectification and a linear envelope
 53, 56, 57
. The 
process is illustrated in Figure 2.18. First, the raw data was imported into MATLAB (Figure 2.18A). Next, 
full wave rectification was completed by obtaining the absolute value of the EMG signal (Figure 2.18B). 
Finally, the linear envelope was generated by using a low pass second order Butterworth filter with a cut 
off frequency of 5 Hz, based off of values obtained in literature (Figure 2.18C)
 53
. Once the EMG signals 
were processed, the maximum value of muscle activation during each contraction was calculated. Figure 
2.19 shows the EMG signal associated with a contraction cycle. The average of the maximum muscle 
activity from the gastrocnemius medial (GMH) and lateral heads (GLH) and the soleus muscle (S) during 
exercise were then added to obtain the total muscle activity for each day of testing. The total muscle 
activity was then normalized by the total muscle activity from the MVC test for that day (an average of two 
MVC tests was used). MVC tests were completed on both days due to the possibility for muscle activation 
to vary between days and also to account for the variation in the locations of the electrodes, though every 
effort was made to place the electrodes at the same location across both testing days.   
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Figure 2.18: GMH muscle activity over a 15 second 
time period illustrating the raw EMG signal (A), the 
rectified signal (B), and the processed signal using a 
low pass second order Butterworth filter with a cut off 
frequency of 5 Hz (C)  
 
(A) 
(B) 
(C) 
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Contraction Cycle Relaxation 
Figure 2.19: Illustration of two contraction cycles (calf raises) where the maximum 
muscle activity value was obtained 
Finally for the applied pressure data, the pressure bladders were attached to the leg with Band-
Aids to ensure their position was maintained when the GCS was applied. The pressure from the Band-Aid 
applied to the bladder was measured and subtracted from the recorded pressure to obtain the applied 
pressure on the leg due to the GCS. The applied ΔP during baseline, exercise, and recovery conditions are 
discussed in Chapter 3. 
2.6     Statistical Analysis  
Repeatability of the GCS tests between days and the control tests with no compression (NGCS) 
between days was determined using four methods. These methods were also used to prove that the order of 
testing had no effect on the results. A two-tailed t-test analysis was used to identify statistically significant 
differences between the tests for both days. The t-value (t) was obtained from Equation 2.11, where the 
difference in the means (  ) from the two days of testing were divided by the standard error measurement 
(σdiff)
 58
. The standard error was calculated, as shown in Equation 2.12, using the standard deviation (SD) of 
the differences between days and the number of subjects (n)
 58
. Once the t-value was known, the p-value (p) 
could be found from the t-distribution table
 58
. Statistical significance occurred if a p-value of less than or 
equal to 0.05 was obtained. The coefficient of variation (COV) was calculated to show variability between 
the tests for the two days using Equation 2.13; the average COV for all subjects is reported in Chapter 3
 59
. 
Bland-Altman plots were used to show agreement between the two days. The Bland-Altman method 
calculated the mean difference between the two days of testing, as well as the 95% limits of agreement 
(   ±1.96 SD) 60. The graphical presentation of the data with the mean and limits of agreements allowed for 
 35 
visual interpretation of how well the measurements from the two days of testing agreed
 60
. Finally, the 
intraclass correlation (ICC) was used to measure consistency in the data and was calculated using 
MATLAB
 61
. Table 2.1 indicates the levels of consistency for the ICC values obtained
 61
.  In order to 
compare the GCS and NGCS tests to determine the effect of compression on physiological variables a two-
tailed paired t-test was used with statistical significance occurring for a p-value equal or less than 0.05.  
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Equation 2.13 
Table 2.1: ICC levels of consistency 
ICC Value Agreement Level 
0 – 0.2 Poor 
0.2 – 0.4 Fair 
0.4 – 0.6 Moderate 
0.6 – 0.8 Strong 
> 0.8 Almost perfect 
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Chapter 3 
Results and Discussion  
 Presented in this chapter are the results of the experimental study on the impact of graduated 
compression socks on athletic performance. The results from a repeatability analysis completed on the 
central and peripheral variables for the two days of testing are presented in Section 3.1. The global 
influence of the GCS on the cardiovascular system is presented in Section 3.2. Finally, the localized 
influence of the GCS on the legs is then discussed in Section 3.3.  
3.1 Repeatability of the effect of GCS on Hemodynamics  
In order to ensure that data collected from the testing protocol was repeatable from one day to the 
next, the testing procedure was performed over a two day span, with a minimum of 48 hours in between 
tests, as outlined in the experimental protocol in Section 2.2. The results are presented for the central 
hemodynamics in Section 3.1.1 and for peripheral hemodynamics in Section 3.1.2.  The repeatability 
analysis completed on each variable involved calculating the p-value, the coefficient of variation, the 
intraclass correlation, and generating Bland-Altman plots, as discussed in Section 2.6.  
3.1.1 Repeatability of the Central Hemodynamic Measurements  
To determine if the effects of the GCS on central hemodynamics were reproducible, repeatability 
analysis was completed on the four central variables measured, namely HR, SBP, DBP, and CO. The 
values obtained from days 1 and 2 were compared for the NGCS and GCS tests for the BL, EX, and REC 
conditions using the p-test procedure outlined in Section 2.6. As shown in Table 3.1, the p-values for all 
variables were significantly larger than 0.05, indicating that there was no statistical difference between data 
collected on different days.  
 
Table 3.1: P-values for central variables comparing data collected on two different days to 
demonstrate test repeatability (values in red indicate statistical significance) 
                                            Condition 
            BL            EX            REC 
Variable NGCS GCS NGCS GCS NGCS GCS 
HR  0.37 0.46 0.43 0.62 0.33 0.60 
SBP  0.31 0.80 0.50 0.83 0.86 0.72 
DBP  0.82 0.87 0.77 0.82 0.58 0.79 
CO  0.88 0.77 0.59 0.47 0.89 0.69 
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The COV and ICC for the baseline, exercise, and recovery conditions with and without GCS are 
shown in Table 3.2. The COV values were close to zero indicating that the values obtained on the two days 
for each subject did not vary significantly from the mean and therefore had low variability. The ICC values 
demonstrated consistency between the data for each subject on both days. HR and SBP showed fair to 
moderate agreement, while CO and DBP showed strong to almost perfect agreement. Finally the Bland-
Altman plots indicated good agreement between the two days of testing. Figure 3.1 shows an example plot 
for the heart rate variable for all conditions for both NGCS and GCS. Figure 3.1 demonstrates good 
agreement as the mean difference, or bias, is close to zero. The majority of the data falls within the 95% 
confidence limits, where the large spacing between the upper and lower limits is acceptable given the 
variation in heart rate between subjects. The remaining Bland-Altman plots for the central variables are 
shown in Appendix D. These results indicated that even with the day to day human variability, the central 
variables were still repeatable and showed no statistical differences, low variability, consistency, and good 
agreement.  
Table 3.2: Coefficient of variation (COV) and intraclass correlation coefficient (ICC) for central 
variables measured over two different days 
  Condition 
              BL            EX          REC 
Variable  NGCS GCS NGCS GCS NGCS GCS 
HR  
COV (%) 7.14 7.72 6.60 6.79 8.25 7.40 
ICC 0.28 0.40 0.43 0.60 0.24 0.52 
SBP  
COV (%) 4.48 6.37 4.50 4.30 3.65 6.54 
ICC 0.69 0.49 0.62 0.69 0.67 0.24 
DBP  
COV (%) 5.10 5.22 4.88 4.33 6.17 6.11 
ICC 0.75 0.72 0.70 0.82 0.70 0.66 
CO  
COV (%) 13.55 8.99 12.99 11.67 11.08 8.09 
ICC 0.70 0.86 0.76 0.81 0.84 0.90 
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Figure 3.1: Bland-Altman plots comparing heart rate (HR) values for two 
days of testing for the baseline (BL), exercise (EX) and recovery (REC) 
conditions for (A) NGCS, and (B) GCS cases. The solid horizontal line 
indicates the mean of the data and the dashed horizontal lines represent the 
95% confidence limits. The upper and lower limits are calculated from the 
mean ± 1.96 of the standard deviation (SD) 
3.1.2 Repeatability of the Peripheral Hemodynamic Measurements  
(A) 
(B) 
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Repeatability analysis was completed on the peripheral measurements for PBVmean, ΔP, and PAD 
to determine if the localized effects due to the GCS were reproducible. The values obtained from days 1 
and 2 were compared for the NGCS and GCS tests for all experimental conditions. Repeatability was only 
analyzed for ΔP during the BL condition, as during this time the applied pressure difference was equivalent 
to that generated by the researchers with the GCS and tensor bandages.  After this point, during EX and 
REC, the researchers were unable to control the pressure difference. The medial, lateral, and average ΔP 
during BL were analyzed. There was no statistical difference between days for any variable with or without 
GCS as illustrated in Table 3.3, which presents the p-values comparing the measured data for both days of 
testing, with and without the GCS.  
 
Table 3.3: P-values for peripheral variables comparing data collected on two different days to 
demonstrate test repeatability (values in red indicate statistical significance) 
  Condition 
  BL EX REC 
Variable  NGCS GCS NGCS GCS NGCS GCS 
PBVmean  0.65 0.67 0.83 0.99 0.64 0.60 
ΔP 
Lateral  - 0.12 - - - - 
Medial  - 0.06 - - - - 
Average - 0.89 - - - - 
PAD  0.81 0.79  -  -     0.66       0.90 
 
The COV and ICC for the peripheral variables for baseline, exercise, and recovery for the NGCS 
and GCS conditions are shown in Table 3.4. For PBVmean, the COV values indicated moderate to low 
variability. The ICC values showed almost perfect agreement for the baseline and exercise conditions. For 
the recovery condition there was moderate agreement for the NGCS test, and poor for the GCS case. These 
results showed that there was consistency in the data for the baseline, exercise, and recovery NGCS tests, 
while for the recovery GCS the results were not consistent. Evaluating the Bland-Altman plot, as seen in 
Figure 3.2, the data had a bias close to zero, the majority of the data points fell within the 95% confidence 
limits, and the interval between the limits of agreement was relatively small for each condition. These 
results demonstrate agreement within the data between the two days of testing.  For ΔP, the COV values 
indicated moderate variability, and the ICC values indicated inconsistency in the data. For PAD the values 
for COV were very close to zero and the ICC values were quite high, indicating that the values obtained 
over both days of testing were consistent and had low variability. The Bland-Altman plots for ΔP and PAD 
indicated good agreement and can be found in Appendix E.  
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Some variability in the PBVmean values was expected due do human variability from day to day, 
and as well as due to the likelihood that the ultrasound probe was not placed in the exact same location on 
each day, despite every effort to do so. The variability in the recovery period during the GCS condition is 
believed to be due to variations in the applied pressure therefore leading to varying responses in PBVmean. 
This variation was only thought to be seen in the recovery portion because the ΔP had changed by varying 
degrees of magnitude depending on the subject due to movement of the sock during the exercise task.  The 
low ICC values in the ΔP data could be due to the fact that it was difficult to obtain the same pressure 
difference on the medial and lateral portions of the leg for both days. When the compression sock was 
placed on the subject’s leg it was extremely difficult to make the local pressure at the ankle and knee the 
same values for the medial and lateral sides. Even when the GCS fibers were aligned properly, the 
geometry changes on either side of the ankle and knee led to varying localized pressure and hence varying 
ΔP values.  
Table 3.4: Coefficient of variation (COV) and intraclass correlation coefficient (ICC) for peripheral 
variables measured over two different days 
   Condition 
   BL EX REC 
Variable   NGCS GCS NGCS GCS NGCS GCS 
PBVmean  
 COV (%) 30.66 15.75 7.61 15.81 26.78 28.45 
 ICC 0.81 0.93 0.98 0.84 0.58 0.16 
ΔP 
Lateral 
COV (%) - 20.11 - - - - 
ICC - 0.01 - - - - 
Medial 
COV (%) - 22.68 - - - - 
ICC - 0.01 - - - - 
Average  
COV (%) - 12.65 - - - - 
ICC - 0.14 - - - - 
PAD  
 COV (%) 1.51 1.96 - - 2.01 1.97 
 ICC 0.97 0.96 - - 0.93 0.97 
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Figure 3.2: Bland-Altman plots comparing mean popliteal blood velocity 
(PBVmean) values for two days of testing for the baseline (BL), exercise (EX) 
and recovery (REC) conditions for (A) NGCS, and (B) GCS cases. The 
solid horizontal line indicates the mean of the data and the dashed 
horizontal lines represent the 95% confidence limits. The upper and lower 
limits are calculated from the mean ± 1.96 of the standard deviation (SD)  
 
3.1.3 Discussion of Repeatability of the effects of GCS  
The repeatability analysis for both days of testing indicated that the protocol and results were 
repeatable.  All efforts were taken to ensure that the protocol was controlled and that the physiological 
(A) 
(B) 
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measurement locations for all variables were the same. Although locations for the measurement devices 
were recorded based off of anatomical landmarks, there was still potential for not placing the probes in the 
exact same locations from one day to the next. Analysis of the repeatability results indicated that the central 
variables had good consistency, stronger agreement, and lower variability than the majority of the 
peripheral variables. Peripherally, PAD measurements also showed very strong agreement and low 
variability, whereas PBVmean results indicated poor to moderate consistency, good agreement, and moderate 
to low variability. Moreover, ΔP values showed inconsistencies, moderate variability, and good agreement. 
No statistical differences were found for any of the tested variables. The results of the repeatability analysis 
were not surprising; strong repeatability was seen in all variables that were not directly related to the 
pressure or region where pressure was applied (PAD and central variables).  The variation in the 
repeatability results for PBVmean and ΔP could be due to human variability from day to day, human error of 
the placement of the pressure bladders and ultrasound probe, as well as the application of the GCS.  
It was important to determine if the results from both days are repeatable to draw confident 
conclusions on the benefits of GCS for a healthy population. The results for the central and peripheral 
hemodynamics during both days of testing are presented in Sections 3.2 and 3.3. 
3.2 Influence of GCS on Central Hemodynamics  
As discussed in Chapter 1, the central hemodynamics is defined as the variables related to the 
heart that affect the entire response of the cardiovascular system. The impact of GCS on the central 
hemodynamics was assessed through bulk cardiac measures, including heart rate, systolic blood pressure, 
diastolic blood pressure, and cardiac output, as described in Section 2.4. The results for the baseline, 
exercise, and recovery conditions are presented in Section 3.2.1 and further discussed in Section 3.2.2.  
3.2.1 Effect of GCS on Heart Rate, Blood Pressure, and Cardiac Output 
Plots comparing HR, SBP, DBP, and CO with and without graduated compression socks for the 
exercise phase of tests run on day 1 are shown in Figure 3.3 to Figure 3.6. The graphs illustrate the change 
from the NGCS to GCS condition; red indicates an increase in the variable with the sock and black 
indicates a decrease in the variable when the sock was worn. Plots for the central variables for the baseline 
and recovery conditions for day 1, as well as all conditions for day 2 can be found in Appendix F. The p-
values obtained for the central variables comparing the NGCS condition to the GCS condition on both days 
are shown in Table 3.5.  
There were no significant changes in HR, DBP, or CO for all phases of the experimental protocol 
between the NGCS and GCS conditions for either day of testing. For SBP, there was no significant 
difference during the BL and REC conditions on day 1, or any condition on day 2. However, during the EX 
condition on day 1 there was a statistical difference between the NGCS and GCS cases (p=0.04). This 
difference is not considered to be due to the addition of the sock, however, since the result was not repeated 
on the second day of testing and blood pressure can vary significantly in general from day to day.  
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Figure 3.3: Comparison of HR with and without GCS during exercise for all 
subjects on day 1 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
 
 
Figure 3.4: Comparison of SBP with and without GCS during exercise for all 
subjects on day 1 (red: increase during the GCS condition, black: decrease 
during the GCS condition 
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Figure 3.5: Comparison of DBP with and without GCS during exercise for all 
subjects on day 1 (red: increase during the GCS condition, black: decrease during 
the GCS condition) 
 
 
Figure 3.6: Comparison of CO with and without GCS during exercise for all 
subjects on day 1 (red: increase during the GCS condition, black: decrease during 
the GCS condition) 
 
40 
60 
80 
100 
120 
D
B
P
 E
X
 (
m
m
H
g
) 
NGCS GCS 
0 
2 
4 
6 
8 
10 
12 
C
O
 E
X
 (
L
/m
in
) 
NGCS  GCS 
 45 
Table 3.5: P-values for central variables comparing data collected for two 
conditions, with and without GCS, for two days of testing (values in red indicate 
statistical significance) 
 Condition 
 BL EX REC 
Variable  Day 1 Day 2 Day 1 Day 2 Day 1 Day 2 
HR 0.09 0.16 0.21 0.42 0.13 0.42 
SBP 0.60 0.32 0.04 0.44 0.32 0.88 
DBP 0.98 0.35 0.48 0.34 0.94 0.28 
CO 0.73 0.41 0.89 0.43 0.74 0.48 
 
The effect of gender was also analyzed to determine if there was a pattern to the manner in which 
each subject behaved when the sock was worn. Figure 3.7 shows a sample of the gender difference analysis 
for HR for day 1 during exercise comparing the values with and without the GCS for all subjects. The x 
symbol represents the male participants and the circles represent the female participants. As demonstrated 
in Figure 3.7, no gender differences were observed for any variable during all conditions.  
 Figure 3.7: Comparison of HR with and without GCS during exercise and the
effects of gender for all subjects on day 1 (red: increase during the GCS 
condition, black: decrease during the GCS condition, x: male, o: female) 
The remaining central variables investigated included MAP, MPP, SV, and TPR. Since these 
variables are calculated based on the four measured central variables, HR, SBP, DBP, and CO (see Chapter 
2), there were no significant differences between the NGCS and GCS conditions. The average values and 
standard deviations for the study population with and without the GCS for each variable are shown in Table 
3.2 for day 1. The information for day 2 can be found in Appendix F.  
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Table 3.6: Calculated mean and SD values for the study population on day 1 for MAP, MPP, SV, and 
TPR 
  Condition 
              BL            EX          REC 
Variable  NGCS GCS NGCS GCS NGCS GCS 
MAP 
Mean 93.59 94.17 99.32 101.61 97.35 98.47 
SD 10.00 9.89 9.67 10.43 9.92 11.58 
MPP 
Mean 161.66 162.24 167.40 169.69 165.43 166.54 
SD 13.27 12.43 12.95 13.85 12.97 13.85 
SV  
Mean 62.47 64.32 76.60 79.02 63.83 66.91 
SD 12.60 16.55 16.00 18.20 16.51 17.63 
TPR 
Mean 16.74 17.50 14.40 14.90 17.69 18.05 
SD 3.13 4.72 2.96 3.76 5.66 6.56 
 
3.2.2 Discussion of the Effect of GCS on Central Hemodynamics  
As illustrated in Section 3.2.1, the comparison of the NGCS and GCS tests for the central 
variables resulted in no significant differences. The outcome that there was no significant change in the 
central variables due to the addition of the GCS was anticipated with such a localized exercise task and 
applied pressure region, only involving the small muscle mass of the calf. It was hypothesized that since the 
investigated region was small, any local physiological changes would not have a substantial effect on 
central variables. The central hemodynamic response was also investigated for trends that may occur with 
the addition of the GCS after no statistically significant differences were found. The trends examined 
included determining if gender played a role in the central response or if the strength of the ΔP affected the 
response of HR, SBP, DBP, or CO. No trends in the data were identified. The result that GCS had no 
significant effect on the central response is similar to those found in literature where the central response 
was either not investigated or no changes were found
 1
. Therefore any beneficial effects from the GCS were 
anticipated to occur at the peripheral level and the results are presented in Section 3.3. 
 
3.3 Influence of GCS on Peripheral Hemodynamics  
As described in Chapter 1, the peripheral hemodynamics refers to those variables affected in the 
local calf region where the external pressure was applied. The variables of interest included vessel 
diameter, arterial popliteal blood velocity and blood flow, muscle oxygenation, muscle activity, and the 
applied pressure. The measurement techniques and analysis completed on all variables are described in 
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Section 2.4 and Section 2.5, respectively. This section is divided into subsections for the three components 
of the experimental protocol (baseline, exercise, and recovery). The results for the variables investigated 
are presented and discussed for each condition in the following sections beginning with baseline in Section 
3.3.1.  
3.3.1 Effect of GCS during Baseline   
3.3.1.1 Effect of GCS during Baseline on PAD, PBV, and PBF 
There were no significant differences in the PAD values during baseline for either day with the 
addition of the sock (day 1: p = 0.95, day 2: p = 0.82). There were also no significant changes in PBVmean or 
PBFmean between the GCS and NGCS conditions (day 1: PBVmean- p = 0.39, PBFmean- p = 0.23; day 2: 
PBVmean- p = 0.17, PBFmean- p = 0.19). The results of PBVmean and PBFmean with and without the GCS for 
the baseline condition are shown in Figure 3.8 and Figure 3.9 for day 1, respectively; the results for day 2 
can be found in Appendix G. These figures demonstrate that there were also no overall trends in the data. 
As illustrated in Figure 3.8, six subjects experienced an increase in PBVmean with the addition of the sock 
(red lines) and six subjects experienced a decrease in PBVmean (black lines). For day two, for the same 
variable, four subjects experienced an increase, and eight experienced a decrease.  These results indicate 
that there were no notable changes in vasculature with the addition of the GCS.  It was hypothesized that 
there would be less pooling in the leg during BL when the sock was worn, however this was not the case. 
No change in blood volume was likely due to the fact that all subjects investigated were healthy and did not 
have any known venous deficiencies, implying that their vasculature performed efficiently in returning 
blood back to the heart. The baseline period was limited to three minutes to allow the body to stabilize; this 
time may not have been sufficient for blood to pool in the legs of the healthy participants. Furthermore, a 
couple of subjects complained of dizziness during the baseline period and therefore were instructed to make 
slight movements with their legs to avoid fainting. These slight movements, which helped enhance venous 
return, may have affected any conclusions to be made about pooling while standing still in a natural 
posture. As previously presented, no significant change in vessel diameter (PAD) with the GCS was 
therefore related to no significant changes in PBFmean. The vessel investigated was not located in the region 
where the external compression was applied and therefore no concrete conclusions can be drawn on 
whether or not the pressure from the sock directly affected the diameters of the superficial and deep veins 
of the lower leg.  
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Figure 3.8: Comparison of PBVmean with and without GCS during baseline for all 
subjects on day 1 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
 
 
Figure 3.9: Comparison of PBFmean with and without GCS during baseline for all 
subjects on day 1 (red: increase during the GCS condition, black: decrease 
during the GCS condition)  
 
3.3.1.2 Effect of GCS during Baseline on the Applied Pressure Difference 
The ΔP was attempted to be maintained to 10 ± 3 mmHg, as discussed in Chapter 2. For day 1, the 
average pressure difference applied to the leg was 13.31 ± 2.43 mmHg and for day 2 the average was 13.47 
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however, the individual differences on the lateral and medial sides varied per day due to the difficulty of 
applying the sock and tensor bandages in the same orientation. For day 1 the ΔP on the medial and lateral 
sides of the legs were 10.57 ± 1.97 mmHg and 16.05 ± 3.59 mmHg, respectively, whereas for day 2 the ΔP 
for the medial and lateral sides were 13.34 ± 4.21 mmHg and 13.61 ± 3.34 mmHg, respectively.  
3.3.2 Discussion of the Effect of GCS during Baseline   
For the peripheral variables during the BL condition there were no significant differences or trends 
found. No change during BL with and without the GCS indicated that the GCS had no effect on the 
vasculature of the lower leg. This result was limited to the conclusions that could be drawn from the 
variables and locations investigated.  Theoretically, when the GCS is applied to the leg, the blood volume 
in the leg should decrease due to a reduction in the diameters of the veins. The lack of impact of the GCS 
during the BL condition could be due to a few factors. The first reason could be that the ΔP was not 
sufficient to cause a change in vasculature in a healthy population with no venous deficiencies. The second 
factor could be the length of the BL condition. The three minute duration may not have been enough time 
to allow a change in vasculature to occur in the healthy study population. The duration of the BL however 
was limited to this time due to some participants experiencing symptoms of syncope (increasing HR with 
decreasing BP). Due to the risk of fainting, all subjects were monitored closely for the initial signs of 
syncope and were asked to make slight movements with their legs to help blood return to the heart. This led 
to a shorter baseline period for those subjects who showed high risk of fainting. Unfortunately, due to this 
unanticipated effect of maintaining the natural posture for a short time there was no way to investigate an 
extended BL due to the risk of fainting and the necessity to have some movement of the legs. In the 
literature review, a limited number of papers studied a BL condition. Similar results were obtained by Stein 
et al. who completed a study on healthy subjects and found no change in popliteal vein blood velocity or 
diameter during rest while supine or seated when wearing GCS
 5
. Following the analysis of the baseline 
condition, the effect of GCS during steady-state exercise was investigated and is presented in Section 3.3.3. 
3.3.3 Effect of GCS during Steady-State Exercise  
3.3.3.1 Effect of GCS during Exercise on PBV and PBF 
There were no significant differences between the NGCS and GCS conditions for PBVmean or 
PBFmean during steady-state exercise (day 1: PBVmean- p = 0.97, PBFmean- p = 0.99; day 2: PBVmean- p = 
0.49, PBFmean- p = 0.45). The exercise data was analyzed in two ways to determine if there were any 
beneficial effects from the GCS. The first method involved comparing the PBVmean and PBFmean values 
during exercise for NGCS and GCS conditions as shown in Figure 3.10 and Figure 3.11 for day 1 (day 2 
plots can be found in Appendix G).  This method was chosen to determine the effect of the GCS with the 
muscle pump activated in conjunction with any changes in the vasculature that may have occurred during 
the baseline condition. The results of the first method revealed a local increase in PBV mean and PBF mean for 
six subjects for day 1 (11.48 ± 4.56 %) and day 2 (13.22 ± 8.61 %) when the GCS were worn. It is 
important to note that the subjects that experienced an increase were not all the same for both days; three 
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subjects experienced an increase on both days. Six subjects experienced a local decrease in PBV mean and 
PBF mean for day 1 (-15.59 ± 13.81 %) and day 2 (-20.18 ± 15.75 %), with three subjects experiencing the 
decrease on both days. The second method involved removing the baseline values from the exercise data 
for each condition to determine whether the change in velocity from baseline was the same with and 
without the GCS. This method isolated the compound effect of the sock and muscle pump (GCS) when 
compared to the sole effect of the muscle pump (NGCS) and removed any effects on vasculature 
experienced during baseline. The results of the second method revealed an increase in PBV mean and PBF 
mean for seven subjects with the addition of the GCS on day 1 (13.59 ± 5.12 %) and day 2 (14.86 ± 9.06 %) 
as shown in Figure 3.12 and Figure 3.13 for day 1 (again, plots for day 2 can be found in Appendix G). The 
second method also indicated a decrease in PBV mean and PBF mean in five subjects on day 1 (-25.86 ± 17.24 
%) and day 2 (-29.12 ± 22.53 %). Again, the subjects who experienced the increase and decrease were not 
all the same for both days, with three subjects having a local increase on both days, and one subject 
decreasing on both days.   
The results of both methods indicated that there are no conclusive trends for PBVmean and PBFmean 
during steady-state exercise, since the majority of subjects did not experience the same response on both 
days. Although the average increase in PBVmean with the addition of the GCS was lower than the average 
decrease in PBVmean without GCS, the standard deviation was considerably lower when the subjects 
experienced an increase. This difference in the SD demonstrates that those subjects who experienced an 
increase in the variables had similar responses, where as those subjects that experienced a decrease had 
very different responses, leading to the large SD values. The fact that the positive or negative effects on 
PBVmean and PBFmean were not repeatable for all subjects on both days could indicate that the negative 
effects may be due to the sock application, and therefore the applied pressure changing from the previous 
testing day.  
 
Figure 3.10: Comparison of PBVmean with and without GCS during exercise for 
all subjects on day 1 (red: increase during the GCS condition, black: decrease 
during the GCS condition)  
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Figure 3.11: Comparison of PBFmean with and without GCS during exercise for all 
subjects on day 1 (red: increase during the GCS condition, black: decrease during 
the GCS condition) 
 
Figure 3.12: Comparison of the change relative to BL values during EX in 
PBVmean with and without GCS for all subjects on day 1 (red: increase during the 
GCS condition, black: decrease during the GCS condition)  
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Figure 3.13: Comparison of the change relative to BL values during EX in 
PBFmean with and without GCS for all subjects on day 1 (red: increase during the 
GCS condition, black: decrease during the GCS condition) 
3.3.3.2 Effect of GCS during Exercise on Muscle Oxygenation  
For muscle oxygenation there were no significant differences in O2Hb or HHb for either day of 
testing. The decreasing trend of HHb on both days when the GCS is worn, as shown in Figure 3.14 and 
Figure 3.15, however, could indicate an increase in muscle oxygenation with the addition of the sock. HHb 
has been utilized as a reliable indicator of changes in muscle oxygenation and oxygen extraction
 62
. 
Although this trend is not statistically significant (day 1: p = 0.10, day 2: p = 0.18), it was repeatable on 
both days, and shows potential that with higher applied pressures, there is the opportunity to increase 
oxygen extraction.  
For total hemoglobin there was a significant decrease (p = 0.003) on day 1 with the GCS 
indicating a reduction in leg blood volume (Figure 3.14). This result is consistent with the prescribed 
function of the GCS, which, as discussed in Chapter 1, is to help prevent pooling in the legs for people 
suffering from venous diseases. There was no significant difference found in tHb with the GCS (p = 0.71) 
for day 2 (Figure 3.15). The significant reduction from day 1 in total hemoglobin in the calf muscle while 
wearing the GCS implied the external compression was able to overcome the local capacitive behaviour of 
the venous system in the leg. For day 2, the majority of subjects experienced lower ΔP values, indicating a 
potential explanation for no significant decrease in tHb. There will also be some variability in the 
capacitive behaviour of the venous system from day to day due to extrinsic factors such as hydration and 
nutrition. Overall, the results of the tHb values on day 1 indicated positive evidence that passive 
compression could impact local blood distribution during exercise. 
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Figure 3.14: Time-averaged muscle oxygenation during EX relative to BL values 
for plantar flexion exercise for day 1 (O2Hb: p = 0.40; HHb: p = 0.09; tHb: p = 
0.003, with * indicating a statistically significant difference)  
 
 
Figure 3.15: Time-averaged muscle oxygenation during EX relative to BL values 
for plantar flexion exercise for day 2 (O2Hb: p = 0.12; HHb: p = 0.18; tHb: p = 
0.71)  
3.3.3.3 Effect of GCS during Exercise on Muscle Activity  
There was no significant change in muscle activity with the addition of the GCS, indicating that 
the same muscle recruitment occurred during both experimental conditions (day 1: p=0.31, day 2: p = 
0.68). The plantar flexion exercise required 52.56 ± 24.81% and 55.73 ± 26.80% of the subjects’ MVC for 
* 
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the NGCS and GCS conditions, respectively on day 1, while on day 2 similar values of 47.42 ± 21.06% and 
48.97 ± 20.01% were recorded. On day 2, there was an error with one subjects EMG signal and therefore 
there was no value available for the GCS test, and only information for the final 40 seconds of exercise for 
the NGCS test. The averages and p-values reported for day 2 therefore include only 11 subjects. The results 
obtained showed a large standard deviation, which is due to the variation in the calf raise height amongst 
the subjects, as well as the variation in their MVC values.   
Table 3.7 presents the individual results for each subject including the calf raise height, the 
exercise frequency declared by the subject (R: regular, IR: irregular), and the percentage of the subjects 
MVC for each test.  
Table 3.7: Percentage of MVC required to complete the exercise task for each subject 
 
 
As stated in Section 1.2, there were two hypotheses: The first hypothesis was that the subject 
would require less muscle recruitment the second time they returned to the lab because they had become 
familiar with the test protocol; the premise being that after completing the task once the muscle would have 
some training and the subject would also be more comfortable completing the task, which could potentially 
generate more fluent motion that requires less muscle activation. This hypothesis was supported by data 
   Day 1 Day 2 
Subject 
Calf Raise 
Height (cm) 
Exercise 
Frequency 
NGCS GCS NGCS GCS 
1 5 R 62.95 54.83 60.19 71.86 
2 6.5 R 66.86 69.21 62.76 64.01 
3 6 R 41.79 37.98 66.00 47.78 
4 5.5 R 21.45 27.14 34.82 30.45 
5 2.5 IR 32.37 41.69 18.61 - 
6 5 R 17.63 18.34 18.47 16.93 
7 4.9 R 32.71 31.99 21.19 17.67 
8 3.3 IR 63.69 57.99 84.11 76.45 
9 3.3 R 74.05 78.70 45.68 52.09 
10 4 R 49.02 48.81 45.65 47.14 
11 4.5 IR 64.59 79.93 47.79 56.40 
12 3.5 IR 103.67 108.07 63.75 57.89 
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from 7 subjects for the GCS condition, and 8 subjects for the NGCS condition. The second hypothesis was 
that the amount of muscle activation required to complete the exercise task is tied to the subject’s lifestyle. 
The percentage of MVC required to complete the exercise protocol was not related to the subject’s 
frequency of exercise. There was, however, a pattern that those participants that stated they exercised 
irregularly had lower calf raise heights when compared to those who declared they exercised regularly 
(average of 3.45 cm for IR vs. 5.03 cm for R). The fact that the majority of participants that declared 
irregular exercise completed lower calf raise heights than those with regular exercise could obscure the 
potential result that the percentage of the MVC required is tied to lifestyle. In order to fully evaluate this 
hypothesis, the calf raise height would have to be maintained at the same value for all subjects. 
3.3.3.4 Effect of GCS during Exercise on the Applied Pressure Difference 
The ΔP during steady-state exercise varied with the plantar flexion exercise, as shown in Figure 
3.16 for one participant. The acquisition of the dynamic pressure measurements allowed for the applied 
pressure to be referenced to the physiological measurements. The blue line represents the pressure applied 
at the ankle, the purple line represents the pressure applied at the knee, and the red line represents the 
PBVmean. Figure 3.16 illustrates two plantar flexion cycles, totaling six seconds. It can be seen that the 
pressure increased while the subject was raising their ankle (UP) due to the movement of the muscles that 
stretch the sock and increase the calf circumference. The velocity decreased during this upward motion as 
the muscle applied more pressure on the arteries, decreasing blood flow. When the subject lowered the 
ankle (DN) the applied pressure decreased as the muscles and GCS returned to their original locations. The 
velocity increased as the increased muscle pressure was removed from the artery when the muscle returned 
to its resting location. During relaxation (RL), the pressure returned to a steady value that was comparable 
to the initial baseline value and velocity returned to the normal pattern seen when a person is standing in a 
natural posture. The result that pressure varied during exercise is important to note for applications of the 
GCS, as the local applied pressure can significantly increase depending on the task completed. If this 
increase in pressure is significant enough it could begin to affect the vasculature in the leg. Although the 
local pressure increased during the plantar flexion, the ΔP, and therefore the driving pressure, did not 
change as the pressure at the ankle and knee increased by relatively the same quantity.  
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Figure 3.16: PBVmean (left ordinate) and applied pressure (right ordinate) during plantar flexion 
exercise (UP: ankle rising, DN: ankle lowering, RL: 1 second relaxation) 
3.3.4 Discussion of the Effect of GCS during Steady-State Exercise   
Analysis of the peripheral variables during steady-state exercise indicated no significant changes 
in PBVmean or PBFmean when the GCS were worn. Although there were also no trends in the data, the 
standard deviation on both days for the subjects that increased were much lower than those that 
experienced a decrease. As previously discussed, this difference demonstrated a uniform response in those 
subjects that experienced a positive effect from the GCS and indicated that those subjects who experienced 
a decrease had varying responses. The variation in the decrease in PBVmean or PBFmean values with the GCS 
were thought to be due to the sock application since the subjects who experienced a positive or negative 
effect were not repeatable for both days. Even though there were no significant differences in the data, the 
variation in the results from day to day for each subject illustrated the importance of the application of the 
GCS. Similar results were found by Stein et al. who studied the effect of ankle exercise (dorsiflexion) on 
healthy subjects in the supine and seated postures
 5
. The researchers found no significant differences in the 
mean popliteal vein velocity, popliteal vein diameter, or mean popliteal vein volumetric flow rate
 5
. 
Although Stein et al. investigated the effect of compression in different postures than this study, when 
standing the pressure in the veins that must be overcome to move blood back to the heart increases 
significantly and therefore if no effect was found in the supine or seated postures, it would not be 
anticipated to see any effect in the standing posture.  
UP DN RL UP DN RL 
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The analysis of the muscle oxygenation indicated positive trends with the addition of the GCS.  
For the first day of testing there was a significant decrease in tHb, indicating a reduction in the leg blood 
volume; on day 2 no statistical significance occurred. The reduction in tHb while wearing the GCS on day 
1 implied the external compression was able to overcome the local capacitive behaviour of the venous 
system in the leg and perform the prescribed task of the GCS. There was also a decreasing trend in HHb on 
both days, which indicated an increase in muscle oxygenation with the GCS. This reduction in HHb 
demonstrated the potential to increase oxygen extraction by applying stronger external compression to the 
calf. The results obtained in this study are consistent with those found by Agu et al. who tested 10 subjects 
with chronic venous insufficiency and investigated muscle oxygenation while completing 10 tip toe 
exercises with and without compression
 25
. The study involved three levels of compression with average 
pressure differences from ankle to knee of 5.60 mmHg (Class I), 9.50 mmHg (Class II), and 15.12 mmHg 
(Class III). The results found significant reduction in HHb for the Class II and III compression levels and a 
reduction in tHb with increasing compression, with a significant reduction found for Class III
 25
. The result 
that a higher pressure difference led to significant differences in HHb and tHb demonstrated the importance 
of the ΔP. The ΔP used in this study was similar to the ΔP for Class III in the Agu et al. study. Since Class 
II or Class III compression was required to show significance during exercise for patients with venous 
deficiencies, it can be deduced that for healthy subjects an even stronger ΔP is required to show statistically 
significant changes with the addition of the GCS.  
There were no significant changes in muscle activity between the NGCS and GCS conditions, 
indicating that the task was repeatable on both days. The trends in the data suggested that less muscle 
recruitment was required to complete the task on the second day as subjects had become familiar with the 
protocol.  Another trend indicated that those subjects who reported irregular exercise calf raised to lower 
heights than those subjects who exercise frequently.  Signs of fatigue were not present in the EMG data for 
any subjects and therefore the plantar flexion exercise task may not have been strenuous enough to assess 
the capabilities of GCS to help reduce fatigue.   
The applied pressure was found to vary during steady-state exercise with the plantar flexion. The 
pressure increased when the ankle was raised and decreased back to baseline values when the ankle was 
lowered. The change was thought to be due to movement of the muscle affecting the circumference of the 
leg. The literature review completed did not encounter many studies where the applied pressure was 
dynamically measured throughout an exercise task on human subjects. Kumar and Alagirusamy studied 
bandage pressure in vitro using a mannequin leg and an air bladder to simulate expansion and contraction 
of the calf muscle
 13
. Their findings showed that the applied pressure increased when the degree of 
expansion or contraction increased or when the bandage was wrapped tighter
 13
. Moreover, McLaren et al. 
developed a system to measure dynamic pressure during exercise and completed initial validation testing so 
the device could be used in further field studies
 63
. The variation in the applied pressure during exercise is 
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important for applications of the GCS. Although no significant change in ΔP was found, the local pressure 
changes indicate that there is potential to affect the vasculature in localized regions. 
The typical use for the GCS in the healthy population is during exercise and recovery conditions. 
As discussed in this section the GCS showed trends towards beneficial effects with a localized exercise 
task, the results for the recovery condition are discussed in Section 3.3.5. 
3.3.5 Effect of GCS during Recovery  
3.3.5.1  Effect of GCS during Recovery on PAD, PBV, and PBF 
There were no significant differences in PAD during recovery for either day when comparing the 
NGCS and GCS conditions (day 1: p = 0.13, day 2: p = 0.75). Additionally, there were no significant 
differences between the baseline and recovery diameters for the NGCS and GCS conditions on day 1 
(NGCS: p = 0.21, GCS: p = 0.99) or day 2 (NGCS: p = 0.98, GCS: p = 0.49). This indicated that the 
exercise task did not result in any lasting effects in the vasculature at the popliteal level. Furthermore, there 
were also no significant differences in PBVmean and PBFmean with the addition of GCS during recovery (day 
1: PBVmean- p = 0.67, PBFmean- p = 0.66; day 2: PBVmean- p = 0.40, PBFmean- p = 0.48) as illustrated in 
Figure 3.17 and Figure 3.18 for all subjects (plots for day 2 can be found in Appendix G). One notable 
trend occurred when comparing the effect of the GCS during BL and REC conditions. During REC for 
PBVmean on day 1, 10 out of the 12 subjects experienced the same response with the GCS as during the BL 
condition (i.e. if a subject experienced an increase in PBVmean during BL, they also experienced an increase 
during REC). This trend holds true on day 2 for PBVmean, where 9 out of 12 subjects behaved the same, as 
well as for PBFmean on both days (day 1: 10/12 subjects, day 2: 8/12 subjects). This trend indicated that no 
carry over effects from exercise occurred during the recovery time and the body was able to experience the 
same effects from the GCS as during the baseline conditions. 
The REC values for PBVmean and PBFmean were compared to the BL values to determine if the 
overall averages were similar for both resting conditions. The REC values for both variables were higher 
than the BL values for the majority of subjects for both NGCS and GCS conditions (day 1: 11/12 subjects, 
day 2: 8/12 subjects). This result was expected as following exercise it will take the body time to return to 
homeostasis conditions. The five minute recovery period may not have been enough for all subjects to 
return to baseline conditions depending on the amount of energy the body required to complete the exercise 
task. The difference between the REC and BL values for the NGCS and GCS conditions were then 
compared to determine if the values when the GCS was worn were closer to BL, potentially indicating a 
faster recovery time. For day 1 for PBVmean, the difference from REC to BL was higher for six subjects 
with the GCS on day 1, and seven on day 2. For PBFmean, the difference was higher with the GCS for 5 
subjects on day 1, and seven on day 2. The results are generally split between subjects who had REC values 
closer to BL with and without the GCS, indicating that there are no trends to show that the sock had any 
effect on immediate recovery (see further analysis in Section 3.3.5.4).  
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Figure 3.17: Comparison of PBVmean with and without GCS during recovery for 
all subjects on day 1 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
 
 Figure 3.18: Comparison of PBFmean with and without GCS during recovery for 
all subjects on day 1 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
 
3.3.5.2 Effect of GCS during Recovery on Muscle Oxygenation  
For muscle oxygenation there were no significant differences for either day of testing when 
comparing the difference between REC and EX for the NGCS and GCS conditions, as seen in Figure 3.19 
and Figure 3.20. There were no repeatable trends in the O2Hb or HHb data; however, the reduction in tHb 
in Figure 3.19 indicated that the difference between REC and EX for tHb on day 1 was smaller when the 
GCS was worn. This signified that the GCS was still maintaining a lower blood volume in the leg during 
REC, when compared to the NGCS case. On day 2, the values for the change in tHb were almost equivalent 
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(Figure 3.20). As previously seen in Figure 3.15, the reduction in tHb was not as significant during EX for 
day 2. Even though the reduction was smaller, the fact that the values are similar for the difference between 
REC and EX showed that the NGCS and GCS values vary from their respective EX values by similar 
amounts. Since the EX values showed a small decrease in tHb it was therefore implied that there was a 
trend towards a lower blood volume with the GCS during REC. This result would be beneficial because it 
would imply that post exercise the GCS was helping to prevent pooling in the leg and maintain the 
movement of blood to replenish the working muscle’s oxygen supply and remove waste.  
 
Figure 3.19: Time-averaged muscle oxygenation for recovery compared to the 
respective exercise values for day 1 (O2Hb: p = 0.14; HHb: p = 0.85; tHb: p = 0.07)  
 
 
Figure 3.20: Time-averaged muscle oxygenation for recovery compared to the 
respective exercise values for day 2 (O2Hb: p = 0.06; HHb: p = 0.16; tHb: p = 0.95)  
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3.3.5.3 Effect of GCS during Recovery on the Applied Pressure Difference  
The ΔP was analyzed immediately following exercise to determine if the pressure difference 
returned to BL values. Due to issues with a slow leak for the pressure sensor at the medial knee location for 
several subjects, only the lateral pressure difference was analyzed. Table 3.8 shows the average lateral ΔP 
and the standard deviation for the 12 subjects for both days for the BL and REC conditions. The change in 
ΔP between conditions fell within the error associated with the pressure system of ±3 mmHg. The SD 
values were higher during the REC conditions as the GCS slipped as the subjects were exercising; the 
degree to which it moved and affected the pressure varied depending on the subject, hence the higher SD 
values. 
Table 3.8: Comparison of the lateral pressure difference measurements for BL and REC conditions 
for both days of testing 
 
 
3.3.5.4 Effect of GCS on Hemodynamic Recovery Time 
The time for each subject to recover to 50% above their average baseline PBVmean was analyzed as 
described in Section 2.5; the results for each subject’s recovery time with and without GCS for both days of 
testing can be seen in Table 3.9. For day 1, half of the subjects had longer recovery times with the GCS, 
while the other half had longer recovery times during the NGCS condition. For day 2, ten subjects 
experienced longer recovery periods with the GCS, while two subjects experienced longer recovery periods 
without the GCS. For the subjects who required longer recovery times with the GCS, the response was 
repeatable for both days. For the subjects who required longer recovery times during the NGCS test, two 
subjects had repeatable responses for both days. For the remaining four subjects on day 2, three had very 
similar times for the GCS and NGCS recovery periods (Table 3.9, Subjects 2, 4, and 9). The remaining 
subject had a completely opposite effect on day 2, as shown in in Table 3.9 for Subject 1. The order of 
testing had no effect on the recovery responses of the subjects. Finally, no statistically significant 
differences were found between recovery times on either day between the NGCS and GCS cases (day 1: p 
= 0.62, day 2: p = 0.08). Since the response of the subjects was split between conditions, no conclusive 
result could be obtained on whether the addition of the GCS was beneficial for hemodynamic recovery 
time. 
 
 Day 1 Day 2 
 BL REC BL REC 
Mean 16.05 14.04 13.61 14.28 
SD 3.59 6.99 3.39 5.19 
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Table 3.9: Time required for subjects to return to 50% above their baseline PBVmean values (time in 
seconds, red: increase during the GCS condition, black: decrease during the GCS condition) 
 
 
3.3.6 Discussion of the Effect of GCS during Recovery 
There were no significant differences in PAD, PBVmean, or PBFmean during recovery with the 
addition of the GCS. The only notable trend was that the majority of subjects experienced the same 
response with the GCS during baseline and recovery. This indicated that there was no carry over effects 
from the plantar flexion exercise into the recovery period. As previously discussed in Section 3.3.2, Stein et 
al. also found similar results
3
. For muscle oxygenation there were no significant differences between the 
NGCS and GCS conditions. There was however, a trend towards lower tHb values indicating that the GCS 
was still maintaining a lower blood volume in the calf post exercise. Bringard et al. investigated muscle 
oxygenation in the calf while standing at rest with the addition of external compression and found that there 
was a decrease in blood volume when the sock was worn, as well as a decrease in the HHb values
 62
.  
Similarly, Agu et al. (previously discussed in Section 3.3.4) studied muscle oxygenation during quiet 
standing and found significant reductions in HHb and a trend toward lower tHb value with the addition of 
external compression
 25
. These studies did not investigate muscle oxygenation post exercise, which could 
account for the differences seen in the HHb values.  
 Day 1 Day 2 
Subject NGCS GCS NGCS GCS 
1 144.04 75.56 63.15 153.3 
2 > 300 293.47 296.90 297.04 
3 26.23 41.11 26.28 78.25 
4 89.26 57.25 42.68 49.69 
5 179.72 87.09 280.31 214.42 
6 77.57 245.51 156.6 216.09 
7 129.92 > 300 52.5 120.63 
8 129.75 292.47 52.6 87.38 
9 295.18 141.99 46.23 56.46 
10 138.45 286.59 248.03 278.59 
11 41.64 31.69 291.8 267.47 
12 158.13 202.86 146.3 166.52 
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The ΔP immediately post exercise was comparable to the baseline values with the difference 
falling within the error associated with the pressure sensor system. The variation in the average ΔP 
increased during recovery compared to baseline was due to slipping of the sock during the exercise task. 
Finally for recovery time there was no conclusive result on whether or not recovery occurs faster with the 
GCS. For half of the subjects the time reach 50% of the BL PBVmean value was longer on both days with 
the GCS, implying that there was a higher PBV value in the leg and therefore a higher PBF value since 
there was no change in PAD. The increase in PBF during recovery suggested that PBF during EX was not 
sufficient and hence created an oxygen deficit in the calf muscles. The body works to replenish this deficit 
by maintaining higher blood flow during recovery until the oxygen debt has been repaid. If this was the 
case for these subjects it is believed that there would have been significant changes between the NGCS and 
GCS conditions during EX and REC in the peripheral variables, however, this did not occur except for 
lower blood volume in the leg with the GCS. Since the response of the PBVmean with the GCS remained the 
same between BL and REC, the GCS was not believed to have had significant carry over effects into the 
recovery period. Since no other variables suggested that there would be a longer recovery period with or 
without the GCS, and the results were not statistically significant, this study implied that the GCS have no 
noteworthy effect on recovery time. The literature review completed found no studies that looked at PBV 
immediately following exercise for comparison purposes as the majority of studies investigate the effect of 
GCS on recovery based on personal opinion of muscle soreness several hours post exercise
 1
.  
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Chapter 4 
Conclusions and Recommendations 
This chapter provides a summary of the results and highlights the key findings of the experimental 
study completed on investigating the impact of GCS on a healthy population. Chapter 4 also presents 
recommendations for future experiments for testing the benefits of GCS during exercise and rest 
conditions.   
4.1 Conclusions 
The goal of this study was to complete a set of controlled experiments to assess the effectiveness 
of passive compression on athletic performance in healthy subjects. The impact of passive compression on 
peripheral and central hemodynamics was investigated at rest, during exercise, and during recovery by 
measuring global and local variables in the cardiovascular system. Centrally, no changes were found in HR, 
CO, SBP, or DBP indicating that the external pressure applied to the legs had no effect on central 
hemodynamics. Peripherally, there were no significant changes in PAD, PBVmean, or PBFmean during any of 
the testing conditions.  During exercise, there was an indication that the subjects who experienced an 
increase in PBVmean or PBFmean with the GCS behaved more consistently than those who experienced a 
decrease, as implied by lower standard deviation values. Moreover, during recovery, there was also no 
significant difference between the PAD values for BL and REC, indicating that the exercise task did not 
result in any lasting effects on the vasculature at the popliteal level. The result that there were no carry over 
effects from EX was also confirmed with a trend in PBVmean and PBFmean, where subjects experienced the 
same response with the GCS during both BL and REC. For muscle oxygenation, results indicated a 
decrease in blood volume in the leg with the GCS, and a trend towards increased muscle oxygenation and 
oxygen extraction during EX. For recovery, there is a trend towards a lower blood volume in the leg with 
the GCS, implying that post-exercise the socks are working to prevent pooling in the leg. For muscle 
activity, there were no significant differences between the NGCS and GCS conditions illustrating that the 
same muscle recruitment was required for both conditions. Furthermore, the locally applied pressure was 
found to vary dynamically during exercise and then return to baseline values during recovery. Moreover, 
the strength of the ΔP was not correlated to the response of the subject with the addition of the GCS. 
Finally, no significant differences were found in the recovery time of PBVmean with the addition of the sock.   
Overall the results found in this study were comparable to other studies investigating the effect of 
GCS on hemodynamics. It is not surprising that there were no changes in central hemodynamics as the 
external pressure was applied in such a small, localized region. It was also not unexpected that a healthy 
study population did not lead to significant changes in vasculature diameter or blood velocity since the 
subjects do not suffer from venous deficiencies and have normally operating cardiovascular systems. This 
study illustrated that the GCS are beneficial in decreasing blood volume in the leg, as expected with their 
prescribed function, and have the potential to increase oxygen extraction in a healthy population. 
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Furthermore, it was discovered that the local applied pressure varied during exercise and this variation 
should be taken into consideration when utilizing GCS for various exercise tasks.  Moreover, this study was 
completed with a high level of control in an attempt to address previous issues found in current research 
and to aid in the development of concrete conclusions on the effect of compression on healthy subjects. The 
findings prove that the applied pressure is extremely important and since this is a variable that is often not 
monitored in current research, it could be a contributing factor as to why there is such variation in the 
reported results. Also, as discussed in Section 1.1.4.2, the majority of studies use individual perception to 
quantify the effect of compression during recovery. The current study presents the effect on hemodynamics 
both before and after exercise to allow for a complete picture of how the GCS affects hemodynamics. This 
study highlights the importance of control and reporting all aspects of the experiment in order to obtain 
high fidelity results that can be entered, with confidence, into the debate of the effectiveness of GCS on 
athletic performance.  
4.2 Recommendations 
For future work involving the investigation of the effect of external passive compression on 
hemodynamics, the following changes to the current study’s experimental protocol are recommended:  
1. Increase the ΔP of the external compression. It is believed that the pressure applied to the leg in this 
study was not substantial enough to generate significant differences in the peripheral variables, 
specifically PAD, PBVmean, PBFmean, or muscle oxygenation. Agu et al. only began to show significant 
differences in muscle oxygenation for subjects with venous deficiencies at ΔP levels of 9.5 mmHg to 
15.12 mmHg
 25
.  
 
2. Control the calf raise height to the same level for all subjects. There was a trend indicating that those 
subjects that reported irregular exercise completed calf raises at lower heights than those who 
exercised frequently. Maintaining a calf raise height slightly above the average value for those who 
reported irregular exercise (i.e. 4 cm) would ensure that all participants could complete the task, as the 
value is low enough to account for the variation in stature and foot size. By controlling the calf raise 
height, the percentage of the subjects’ MVC required to complete the exercise task could be compared 
and indications of fatigue or the effect of exercise frequency could be derived.  
 
3. Increase the duration of plantar flexion exercise to determine the effect of the GCS during fatigue. The 
results of this study indicated no significant carry over effects from the EX condition into the REC 
period. By increasing the duration of the exercise task, subjects could be pushed to their fatiguing 
levels and the effect of the GCS during fatigue could be investigated to determine if the sock has 
beneficial effects in enhancing performance.  
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4. Employ a more demanding exercise task in the experimental protocol. Utilizing a more demanding 
exercise task that requires larger muscle recruitment (e.g., running) where higher blood flow demands 
are placed on the body may elicit more significant and measurable changes in the central variables.  
 
5. Map the pressure distribution of the GCS on the calf. Currently only four sensors are placed at the knee 
and ankle of the medial and lateral sides of the leg to provide insight into the ΔP driving changes in 
hemodynamics. Since no significant changes were observed in central or peripheral hemodynamics in 
this study it is believed that gaining a better understanding of the pressure over the entire calf could aid 
in the explanation of the hemodynamic response in future studies.   
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Appendix A: EMG Comparison of Walking and Plantar 
Flexion 
A small study was completed on two subjects to determine the difference in muscle activity during 
walking and plantar flexion. The subjects were instructed to walk on a treadmill for five minutes at a speed 
that they felt was similar to their normal walking pace (Subject 1: 2.6 mph, Subject 2: 3.5 mph). On a 
separate day, the muscle activity during five minutes of plantar flexion was investigated. The total muscle 
activity in the gastrocnemius muscle was compared for both cases. The soleus muscle was later added to 
the GCS study to investigate the entire activation of the calf and therefore it was not investigated in this 
study. The results are illustrated in Table A.1 and indicate that for Subject 1 the plantar flexion task 
required approximately 19 % more than walking at normal pace, and for Subject 2 the plantar flexion task 
required 41 % less than normal walking pace. The variation between the two subjects is due to gender, 
height, weight, and therefore normal walking pace. There is also the potential for error as the treadmill and 
calf raise task were completed on two separate days therefore some human variability will exist as well as 
the potential that the EMG electrodes were not placed in the exact same locations on both days. This study 
indicates that the muscle activation for the plantar flexion task is similar to walking and would correspond 
well to subjects walking at slower speeds where less muscle activation is required.  
Table A.1: Comparison of the total muscle activation in the gastrocnemius for plantar flexion and 
walking 
Subject 
Plantar 
Flexion (mV) 
Walking (mV) 
1 0.88 0.71 
2 0.38 0.64 
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Appendix B: Participant Protocol and Health Forms 
The following forms were provided to the participants upon arrival to the lab for testing. Small 
changes were made to the protocol described in the Information Letter as discussed in Chapter 2. These 
changes were made clear to the subjects before consenting to the experiment. The health forms were 
assessed before beginning the protocol to ensure that the experiment was safe for each subject.  
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INFORMATION LETTER 
 
 
 
You have been invited to take part in a research study. This letter will outline the purpose of the project, 
describe the procedures that are required, tell you about potential risks and benefits to yourself, and discuss 
your rights and confidentiality issues. If you wish to participate, you will be asked to sign a consent form at 
the time of the study. Feel free to ask any questions you might have at any time. 
Study Title: 
Can cardiac function be improved by increasing venous return via external compression of the lower 
legs? 
Researchers and Contact Information: 
Sean Peterson, PhD           phone: 519-888-4567 ext 38722     e-mail: peterson@uwaterloo.ca 
Richard Hughson, PhD     phone: 519-888-4567 ext 32516     e-mail: hughson@uwaterloo.ca 
Department of Mechanical and Mechatronics Engineering, Centre for Bioengineering and Biotechnology, 
University of Waterloo, Waterloo, ON, N2L 3G1 
Department of Kinesiology, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, ON, 
N2L 3G1 
Student investigator 
Jennifer Book                 phone: 519-888-4567 ext 38722     e-mail: jlbook@uwaterloo.ca 
Collaborators 
Rodrigo Villar, PhD      phone: 519-888-4567 ext 38073     e-mail: rvillar@uwaterloo.ca 
Chekema Prince, Msc   phone: 519-888-4567 ext 38722     e-mail: cprince@engmail.uwaterloo.ca 
What is the purpose of this study? 
 This research is designed to determine the effect on cardiac function by increasing venous return via 
external compression of the lower leg. The understanding of the effect of compression on venous return can 
bring new insights about improvement of cardiac function with workload reduction on the heart and cardiac 
system in different populations, such as; cardiovascular disease, peripheral vascular disease, workers with 
regular and sustained periods of exercise and athletes. Such information can be used to create new tools and 
strategies to improve cardiovascular responses to challenges of daily living activities as well as recreational 
and sports activities having a direct impact on the quality of life. The study data will be used for Jennifer 
Book Master's thesis. 
What will I be asked to do? How much time will it take? 
Cardiorespiratory &Vascular
Dynamics Lab
University of Waterloo
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Participants will be asked to attend two laboratory sessions. In the first session, participants will be asked to 
complete the consent form, health status form and par-Q questionnaire that will be reviewed by researchers 
Rodrigo Villar, PhD and Jennifer Book (student investigator). The participant’s height and weight will then 
be measured and a familiarization of the procedures will be completed, including data collection and 
protocols that will be used in this study. Next the arteries and veins of the lower legs will be identified 
using Doppler ultrasound. The participant may ask as many questions as they want to clarify the 
information presented. In the second session, the participant will be asked to stand-up and hold a custom 
designed frame to provide support while standing on one leg. Their body weight will be supported by the 
left leg on a wood platform and their right leg will be free with no support with the ankle kept at a 90º 
angle. Next, the participant will be asked to wear a graduated compression sock on the right leg and stand-
up again using the frame for support to perform plantar flexion (calf raises) exercise for 6 minutes. Heart 
rate, blood pressure, cardiac output, artery and vein diameters and velocities and muscle activity will be 
continuously measured during the tests. The total time commitment will be 6 hours (2-3 hours per day of 
testing). All of these measurements used are non-invasive and all procedures will be taken by trained 
researchers. 
Am I eligible? 
This study focuses on 18-40 years old healthy men and women. You will be asked to complete a Health 
Status Form that determines eligibility for the study. This one-page form will ask important information 
about your health, including past and current medical conditions and current medications. Smokers and 
those with any current medical problem related to cardiovascular disease, kidney disease, chronic 
inflammatory disease, diabetes, neurological disorders or skin sensitivity (i.e., psoriasis) will be excluded 
from participation in this study. 
What are the procedures?  Will there be any risk involved? 
On arrival at the laboratory, your height and weight will be measured and you will fill out the Physical 
Activity Readiness Questionnaire (PAR-Q) and the medical screening form. We will ask you to stand-up 
and hold the custom designed frame, which will be adjusted to provide optimal comfort for you. Your right 
foot will be free with no support while your left leg will step on a support. Then, heart rate, blood pressure, 
cardiac output, blood velocity, blood vessel diameter, blood flow and muscle activity will be measured at 
baseline. After baseline measurements are taken you will be asked to wear a graduated compression sock 
on your right leg and repeat the standing test as previously described. Following, you will be asked to place 
both feet on the ground to perform 6 minutes of exercise (calf raises). Heart rate, blood pressure, cardiac 
output, blood velocity, blood vessel diameter, blood flow and muscle activity will be measured during 
standing and exercise phases. All of these measurements used are non-invasive and all procedures will be 
taken by trained researchers. The non-disposable equipment will be sanitized between uses by alcohol 
wipes. 
Heart Rate measurements 
Heart rate will be continuously monitored beat by beat by an electrocardiogram (ECG) through 3 spot 
electrodes on the skin surface. The disposable electrodes are normally placed in the upper and lower 
portions of the chest (two on the left side and one on the right side). The ECG electrodes will be placed by 
a researcher of the same sex. In a very small group of individuals, a skin rash might occur due to the 
adhesive on the electrodes.  There is no way of knowing this ahead of time. The rash, if it develops, will 
resolve itself within a day or so.  Avoid scratching the rash and keep the area clean. 
Blood Pressure measurements 
Arterial blood pressure will be measured by a small cuff placed on the middle finger and from a cuff placed 
around your upper arm. This device applies light pressure around the finger in order to determine the 
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pressure in these arteries. Any discomfort should be minimal with this measurement system. In case of 
discomfort, please notify the researcher immediately.   
Cardiac output measurements ( Q ) 
Cardiac output ( Q ) will be estimated from the finger arterial pulse wave by a small cuff placed on the 
middle finger. From a cuff placed around your upper arm the brachial arterial wave will be reconstructed 
based on the finger arterial wave through a modelflow algorithm method to represent the shape of the aortic 
waveform. This model includes age, sex, height, and weight as factors to estimate stroke volume. Cardiac 
output values will be calculated as a product of heart rate and stroke volume measurements. 
 
Ultrasound Measurements of blood flow velocity and blood vessel diameters 
Ultrasound is a non-invasive technique used to measure the velocity of red blood cells moving through the 
arteries and to image the blood vessels. The blood flow velocity will be measured in the popliteal artery in 
the back of the leg (popliteal fossa located in the back of the knee) by Doppler ultrasound. A probe will be 
placed over the skin with the ultrasound directed toward the blood vessel and this probe will be held by the 
researcher. The probe will be adjusted to the minimum power level necessary to obtain a clear signal. At 
this level you should not notice any sensation.  This method is widely used. However, in the unlikely 
event that you should feel a sharp pain or burning, please inform the experimenter immediately.  In 
the very unlikely case that a skin burn should occur, it should be treated as any other burn by application of 
cold compress, first aid cream and sterile covering. The procedure involves the use of water soluble 
ultrasound gel. It can be removed simply by applying water and wiping the skin and/or hair with a paper 
towel or a cloth. The arteries and veins will be imaged by the use of echo Doppler ultrasound. This 
technique is entirely non-invasive. The probe will be held against the skin in the back and front of the lower 
leg to image the diameter of the arteries and veins as well as obtain blood velocity tracings. Ultrasound 
monitoring requires the use of water-soluble, hypoallergenic gel between the probe and the surface of the 
skin. Ultrasound procedures will be conducted by a researcher delegated to do so by a physician under the 
Delegation of a Controlled Act. 
Muscle activity measurements  
Muscle activity will be measured by electromyography (EMG) through 7 skin surface electrodes. The 
disposable electrodes are placed on the lower leg on the right and left gastrocnemius, specifically in the 
biggest portion of the muscle (maximum circumference) and soleus muscles placed beside the 
gastrocnemius tendon. Before the electrodes are placed, the area will be sterilized with alcohol and cleaned 
with cotton balls. The hairs will be shaved by a disposable razor to allow better signal during data 
collection. This procedure is safe.  In a very small group of individuals, a skin rash might occur due to 
the adhesive on the electrodes.  There is no way of knowing this ahead of time. The rash, if it develops, 
will resolve itself within a day or so.  Avoid scratching the rash and keep clean. 
Are there any special instructions I should follow? 
We will request that you refrain from consuming alcohol, caffeinated beverages, and from engaging in 
vigorous exercise (that is, exercise where you are breathing so hard that you would be unable to carry on a 
conversation) 24 hours prior to testing. We also request that you do not eat a large meal within 2 hours of 
testing. You should wear comfortable exercise clothing such as shorts, t-shirt, socks and -sneakers. 
Will I benefit from this study? 
There are no direct benefits to participation in the study. You will gain more knowledge about the effects of 
passive and active compression on cardiovascular hemodynamic responses, the research process, and 
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appreciate the types of changes that can happen during these procedures. It is important to understand if 
compression can affect cardiovascular hemodynamics by improving the return of blood back to your heart 
through the veins and therefore decreasing the heart workload. This study may have implications for 
different populations such as increasing performance by athletes, decreasing fatigue for workers that spend 
a lot of time standing or walking (soldiers, firefighters, police officers, delivery workers) and improving 
circulation for older people, people with cardiovascular diseases or peripheral vascular disease. If 
requested, you will be provided a feedback letter concerning the responses of all participants as soon 
as possible following the completion of the study. 
Will I be rewarded for volunteering my time? 
There will be no remuneration for this study. 
Can I withdraw from the study? 
Your participation in this study will be voluntary. You may withdraw from the study without penalty or 
any consequences by making the researchers aware of your decision. 
How confidential and secure is my personal information? 
Each participant will be identified by a special identification code known by the main investigator and the 
research assistants. After all of the identifying information has been removed, the data will be kept for 25-
years in an encrypted format in a password-protected secure location, locked in the Cardiorespiratory and 
Vascular Dynamics Laboratory in Burt Mathews Hall 2421 at the University of Waterloo. The results will 
be used for publications in conferences, papers, and reports. The participant’s name or any type of 
identification information will be not included to maintain confidentiality. 
Has this study received ethics clearance? 
This project has been reviewed and received ethics clearance through a University of Waterloo Research 
Ethics Committee (ORE# 19454). You may contact the Director at the University, Maureen Nummelin, 
PhD, by phone at 519-888-4567, ext 36005, or by email at maureen.nummelin@uwaterloo.ca with any 
comments or concerns about your participation in this study. 
We would like to remind you that if you have questions, you can contact us at any time. Our contact info is 
on the first page of this letter. Thank you for considering our study. 
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CONSENT OF PARTICIPANT 
 
 
Study Title: 
Can cardiac function be improved by increasing venous return via external compression of the lower 
legs? 
Researchers and Contact Information: 
1
Sean Peterson, PhD          phone: 519-888-4567 ext 38722     e-mail: peterson@uwaterloo.ca 
2
Richard Hughson, PhD    phone: 519-888-4567 ext 32516     e-mail: hughson@uwaterloo.ca 
Student investigator 
1
Jennifer Book                   phone: 519-888-4567 ext 38722     e-mail: jlbook@uwaterloo.ca  
Collaborators 
1
Chekema Prince, Msc      phone: 519-888-4567 ext 38722     e-mail: cprince@engmail.uwaterloo.ca 
2
Rodrigo Villar, PhD         phone: 519-888-4567 ext 38073     e-mail: rvillar@uwaterloo.ca 
1
Department of Mechanical and Mechatronics Engineering, Centre for Bioengineering and Biotechnology, 
University of Waterloo, Waterloo, ON, N2L 3G1 
2
Department of Kinesiology, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, ON, 
N2L 3G1 
 I have read the information presented in the information letter about the procedures and risks involved 
in this study. I have had the opportunity to ask any questions related to the study and have received 
satisfactory answers. I am aware that I may withdraw from the study without penalty at anytime by making 
the researchers aware of this decision. If I have any further questions about participation in this study I 
know that I may contact Richard Hughson, PhD, by phone at 519-888-4567, ext. 32516, or by e-mail at 
hughson@uwaterloo.ca. 
 This project has been reviewed and received ethics clearance through a University of Waterloo 
Research Ethics Committee (ORE# 19454). I was informed that I may contact the Director, Maureen 
Nummelin, PhD, at 519-888-4567, ext. 36005, or by e-mail at maureen.nummelin@uwaterloo.ca with any 
comments or concerns about my participation in this study.  
 With full knowledge I agree, on my own free will, to be a participant in the research project identified 
above. I am aware that by signing the consent form, I am not waiving my legal rights or releasing the 
investigator(s) or involved institution(s) from their legal and professional responsibilities. 
____________________________  ____________________________ 
Participant (print name)    Participant (signature) 
____________________________   ____________________________ 
Witness (print name)    Witness (signature) 
____________________________   ____________________________ 
Date      Location 
Cardiorespiratory &Vascular
Dynamics Lab
University of Waterloo
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HEALTH STATUS FORM 
Study: Can cardiac function be improved by increasing venous return via external compression of the lower 
legs?         ID#: ___________________ 
SELF REPORT CHECK LIST 
Health Problems 
Rheumatic Fever  (  ) Bleeding disorders (  )   
Diabetes   (  ) Kidney and liver disease (  )  
Heart Murmur  (  ) Anemia                (  ) 
High Blood Pressure (  ) Epilepsy   (  ) 
High Cholesterol  (  )  Varicose Veins  (  ) 
Congenital Heart Disease (  ) Disease of Arteries (  ) 
Heart Attack  (  ) Emphysema, Pneumonia (  ) 
Heart Operation  (  )   
Heartburn  (  )  Back Injuries  (  ) 
Raynaud's disease (  ) Arthritis   (  ) 
Bleeding from Intestinal Tract (  ) Peripheral vascular disease  (  ) 
Enteritis/colitis/diverticulitis    (  )  
 
Drug reactions, food allergies and allergies and sensitivities to gels or adhesives 
(specify):______________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________ 
List medications or vitamin supplements taken in last 3 months: 
1.__________________________________________3._________________________________________ 
2.__________________________________________4._________________________________________ 
 
For females: Pregnant ____ Nursing ___ 
List of symptoms 
Irregular Heart Beat (  ) Fatigue   (  ) 
Chest Pain  (  ) Cough Up Blood  (  ) 
Short of Breath  (  ) Back Pain/Injury                (  ) 
Persistent Cough  (  ) Leg Pain-Injury  (  ) 
Dizziness  (  )  
Habits: Smoking: Never (  ) Ex-smoker (  ) Regular (  ) Average # cigarettes/day (  ) 
Exercise: Never (  ) Irregular (  ) Regular (  )   Specify: 
______________________________________________________________________________________ 
Researchers name: Rodrigo Villar, PhD and/or Jennifer Book 
Signature of Researcher:_________________________________________________________________ 
Date:___________________ 
 
The current study has been identified as requiring medical clearance:   Yes (    )  No  (X) 
 
Smokers and those with any current medical problem related to cardiovascular disease, kidney 
disease, chronic inflammatory disease, diabetes, neurological disorders or skin sensitivity (i.e., 
psoriasis), peripheral vascular disease and Raynaud's disease will be excluded from participation in 
this study. 
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Appendix C: Validation of the Pressure Sensor System 
The pressure sensor system was calibrated using a series of hydrostatic tests. Each of the 16 
bladders were submerged in water to a known depth. The applied pressure (P) is a function of depth as 
shown in Equation C.1, where ρ is the density of the fluid, g is the gravitational acceleration, and h is the 
depth of the pressure sensor with respect to the surface of the fluid.  
 
      Equation C.1 
The applied pressure obtained from the pressure sensor system was compared to the expected pressure, 
calculated from Equation C.1. The results are shown in Figure C.1 where the reading from the transducer is 
compared to the calculated pressure. The experimental pressures obtained match closely to the calculated 
expected pressures. The greatest disparity between the calculated pressure and the measured pressure is 
approximately 8% over the entire pressure transducer’s range 52. This maximum difference correlated to a 
value of approximately 3 mmHg and this value was used as the measurement error in the pressure system. 
Taking into consideration the possible errors that could be introduced into the calculated pressure including 
human error, the surface tension of the water affecting a precise h measurement, and the deformation of the 
sensor while submerged in the fluid, the pressure values showed good correlation.  
 
Figure C.1: Pressure measurements from the NIST calibrated pressure sensor graphed vs. the 
theoretical pressure
 52
 
A second series of hydrostatic tests were completed on a mannequin leg to mimic the test protocol. 
Two banks of sensors (eight sensors in total) were tested three times and plotted against the expected 
pressure as seen in Figure C.2 and Figure C.3. Since these two banks of sensors demonstrated good 
correlation and the previous individual hydrostatic tests led to the same conclusion, the remaining two 
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banks were not tested.  After the completion of the hydrostatic tests, the pressure system was validated and 
it was established that the pressure sensor system was measuring the actual applied pressure to the sensor.  
 
Figure C.2: Comparison of the hydrostatic test results for three tests completed on 
pressure sensor 9 to 12 compared to the expected pressure  
 
 
Figure C.3: Comparison of the hydrostatic test results for three tests completed on 
pressure sensor 13 to 16 compared to the expected pressure 
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Appendix D: Bland-Altman Plots for Central Variables 
The following figures show the Bland-Altman plots for the remaining central variables. As stated 
in Chapter 3, the plots show good agreement within the 95% confidence levels contributing to the 
conclusion that the results were repeatable between days.  
 
    
Figure D.1: Bland-Altman plots comparing SBP values for two days of 
testing for the BL, EX and REC conditions for (A) NGCS, and (B) GCS. 
The solid horizontal line indicates the mean of the data and the dashed 
horizontal lines represent the 95% confidence limits. The upper and 
lower limits are calculated from the mean ± 1.96 of the SD.  
(A) 
(B) 
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Figure D.2: Bland-Altman plots comparing DBP values for two days of 
testing for the BL, EX and REC conditions for (A) NGCS, and (B) GCS 
cases. The solid horizontal line indicates the mean of the data and the 
dashed horizontal lines represent the 95% confidence limits. The upper 
and lower limits are calculated from the mean ± 1.96 of the SD. 
 
 
(A) 
(B) 
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Figure D.3: Bland-Altman plots comparing CO values for two days of 
testing for the BL, EX and REC conditions for (A) NGCS, and (B) GCS 
cases. The solid horizontal line indicates the mean of the data and the 
dashed horizontal lines represent the 95% confidence limits. The upper 
and lower limits are calculated from the mean ± 1.96 of the SD. 
 
(A) 
(B) 
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Appendix E: Bland-Altman Plots for Peripheral Variables 
The following figures show the Bland-Altman plots for the applied pressure and diameter 
measurements. As discussed in Chapter 3, the plots show good agreement within the 95% confidence levels 
leading to the conclusion that the results had good agreement between days.  
 
Figure E.1: Bland-Altman plot comparing the pressure difference, ΔP, 
for the two days of testing on the lateral and medial sides of the leg as 
well as the overall average pressure difference. The solid horizontal 
line indicates the mean of the data and the dashed horizontal lines 
represent the 95% confidence limits. The upper and lower limits are 
calculated from the mean ± 1.96 of the SD. 
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Figure E.2: Bland-Altman plots comparing the popliteal artery diameters 
(PAD) during BL and REC for two days of testing for (A) NGCS, and (B) 
GCS conditions. The solid horizontal line indicates the mean of the data 
and the dashed horizontal lines represent the 95% confidence limits. The 
upper and lower limits are calculated from the mean ± 1.96 of the SD. 
 
 
(A) 
(B) 
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Appendix F: Central Variables NGCS and GCS Comparison 
Graphs 
The following figures illustrate the comparison of the values obtained during the NGCS and GCS 
tests for HR, SBP, DBP, and CO. Figures D.1 to D.8 show the comparisons for the baseline and recovery 
conditions for day 1, while Figures D.9 to D.20 show the results for all conditions for day 2. For all graphs, 
red indicates an increase in the variable during the GCS condition, and black indicates a decrease in the 
variable when the sock is worn. Table D.1 shows the obtained values for MAP, MPP, SV, and TPR for day 
2 of testing. As discussed in Chapter 3, no significant differences were found between conditions for the 
central variables.  
 
Figure F.1: Comparison of HR with and without GCS during baseline for all 
subjects on day 1(red: increase during the GCS condition, black: decrease during 
the GCS condition) 
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Figure F.2: Comparison of SBP with and without GCS during baseline for all 
subjects on day 1(red: increase during the GCS condition, black: decrease during 
the GCS condition) 
 
 
Figure F.3: Comparison of DBP with and without GCS during baseline for all 
subjects on day 1(red: increase during the GCS condition, black: decrease during 
the GCS condition)  
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Figure F.4: Comparison of CO with and without GCS during baseline for all 
subjects on day 1(red: increase during the GCS condition, black: decrease during 
the GCS condition)  
 
 
Figure F.5: Comparison of HR with and without GCS during recovery for all 
subjects on day 1(red: increase during the GCS condition, black: decrease during 
the GCS condition) 
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Figure F.6: Comparison of SBP with and without GCS during recovery for all 
subjects on day 1(red: increase during the GCS condition, black: decrease during 
the GCS condition)  
 
 
Figure F.7: Comparison of DBP with and without GCS during recovery for all 
subjects on day 1(red: increase during the GCS condition, black: decrease during 
the GCS condition)  
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Figure F.8: Comparison of CO with and without GCS during recovery for all 
subjects on day 1(red: increase during the GCS condition, black: decrease during 
the GCS condition)  
 
 
Figure F.9: Comparison of HR with and without GCS during baseline for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
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Figure F.10: Comparison of SBP with and without GCS during baseline for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
 
 
Figure F.11: Comparison of DBP with and without GCS during baseline for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
 
80 
100 
120 
140 
160 
180 
S
B
P
 B
L
 (
m
m
H
g
) 
NGCS GCS 
40 
60 
80 
100 
120 
D
B
P
 B
L
 (
m
m
H
g
) 
NGCS GCS 
 93 
 
Figure F.12: Comparison of CO with and without GCS during baseline for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
 
 
Figure F.13: Comparison of HR with and without GCS during exercise for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
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Figure F.14: Comparison of SBP with and without GCS during exercise for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
 
 
Figure F.15: Comparison of DBP with and without GCS during exercise for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
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Figure F.16: Comparison of CO with and without GCS during exercise for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease during 
the GCS condition) 
 
 
Figure F.17: Comparison of HR with and without GCS during recovery for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease during 
the GCS condition) 
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Figure F.18: Comparison of SBP with and without GCS during recovery for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
 
 
Figure F.19: Comparison of DBP with and without GCS during recovery for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease during 
the GCS condition) 
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Figure F.20: Comparison of CO with and without GCS during recovery for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease during 
the GCS condition) 
 
Table F.1: Calculated mean and SD values for the study population on day 2 for MAP, MPP, SV, and 
TPR  
  Condition 
              BL            EX          REC 
Variable  NGCS GCS NGCS GCS NGCS GCS 
MAP 
Mean 96.16 94.20 99.42 100.67 95.99 97.17 
SD 12.26 9.69 11.01 8.69 11.58 7.64 
MPP 
Mean 164.24 162.28 167.49 168.74 164.06 165.25 
SD 15.81 13.35 14.86 12.73 14.67 11.17 
SV  
Mean 64.47 65.49 75.57 75.59 67.11 66.93 
SD 21.41 20.55 27.97 28.36 22.77 21.00 
TPR 
Mean 18.71 18.30 16.82 17.19 18.31 18.63 
SD 6.03 4.62 7.06 6.35 6.63 5.84 
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Appendix G: Day 2 Graphs for PBVmean and PBFmean 
The following figures illustrate the comparison of the PBVmean and PBFmean values obtained during 
the NGCS and GCS tests for BL, EX, and REC conditions for day 2 of testing.  For all graphs, red indicates 
an increase in the variable during the GCS condition, and black indicates a decrease in the variable when 
the sock is worn. As discussed in Chapter 3, no significant differences were found between conditions for 
either variable.  
 
Figure G.1: Comparison of PBVmean with and without GCS during baseline for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
 
 
Figure G.2: Comparison of PBFmean with and without GCS during baseline for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition) 
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Figure G.3: Comparison of PBVmean with and without GCS during exercise for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition)  
 
 
Figure G.4: Comparison of PBFmean with and without GCS during exercise for all 
subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition)  
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Figure G.5: Comparison of the change relative to BL values during EX in 
PBVmean with and without GCS for all subjects on day 2 (red: increase during the 
GCS condition, black: decrease during the GCS condition)  
 
 
 
Figure G.6: Comparison of the change relative to BL values during EX in 
PBFmean with and without GCS for all subjects on day 2 (red: increase during the 
GCS condition, black: decrease during the GCS condition) 
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Figure G.7: Comparison of PBVmean with and without GCS during recovery for 
all subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition)  
 
 
Figure G.8: Comparison of PBFmean with and without GCS during recovery for 
all subjects on day 2 (red: increase during the GCS condition, black: decrease 
during the GCS condition)  
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